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Abstract 
Protein synthesis can be divided into three distinct subprocesses, namely initiation, 
elongation and termination. During the initiation phase, the elongation competent 
ribosome, which harbors the initiator tRNA in its P-site base-paired with the start 
codon of the mRNA, is assembled. Translation initiation is the most regulated and 
rate-limiting step. In eukaryotes, at least 12 distinct translation initiation factors 
(eIFs) facilitate this critical process. 
The largest among these factors is the multi-subunit complex eIF3 (6 subunits 
in yeast, 13 subunits (a-m) in mammals). eIF3 is involved in nearly all steps of the 
initiation process. However, the structure of eIF3 and the mechanism of its versatile 
functions are still largely elusive. In this work, the functional eIF3 core that is 
formed by 5 universally conserved subunits (a, b, c, g, and i) was reconstituted 
in vitro, and the interaction network was further explored. Within the 5-subunit 
eIF3 core, the b subunit (eIF3b) is shown to serve as the major scaffold. The crystal 
structure of the WD40 domain of Chaetomium thermophilum eIF3b was solved de 
novo by means of MAD. The structure revealed an unexpected nine-bladed WD40 
β-propeller fold. It possesses a central channel that exhibits a circular truncated 
cone shape rather than the common cylindrical form. Sequence analysis suggests 
that this nine-bladed propeller architecture is adopted by all eIF3b orthologs. Based 
on its unique shape, the WD40 β-propeller of eIF3b was unambiguously fitted into 
the recently published cryo-EM map of the 43S preinitiation complex (PIC) (EMDB 
code: 5658). Due to this ribosomal location, underneath the shoulder of the 40S 
subunit, eIF3b is indicated to directly interact with the 40S ribosomal subunit. 
Consistently, stable interactions between eIF3b and the isolated ribosomal protein 
S9e, as well as the 40S subunit were observed using in vitro binding assays. Hence, 
these results strongly indicate a direct involvement of eIF3b in the assembly of the 
43S PIC.  
    The initiator tRNA bound 43S PIC is recruited to the 5’ untranslated region of 
the mRNA in a manner facilitated by eIF4F. eIF4F is a heterotrimeric complex, 
	  
	   vi 
consisting of the m7G cap-binding protein eIF4E, the ATP-dependent RNA helicase 
eIF4A and the multi-scaffold eIF4G. eIF4A melts secondary structures in the 
5’ UTR for recruitment of the 43S PIC and subsequent scanning. However, the 
helicase and ATPase activities of isolated eIF4A are very low. High activities occur 
only when eIF4B and eIF4G are present. In this thesis, a potential RNA-binding 
fragment of eIF4G is shown to be indispensable for the efficient stimulation. The 
RNA binding ability and ATPase activity of eIF4A was dramatically increased in 
the presence of an eIF4G variant that contains eIF4A- and RNA-binding regions. By 
contrast, an eIF4G truncation containing the eIF4A-binding domain only did not 
show any enzymatic enhancement. These findings suggest that eIF4G enhances the 
activities of eIF4A through simultaneous interactions with eIF4A and RNA, and 
providing the RNA substrate for eIF4A. This model was further supported by 
site-specific crosslinking experiments.  
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1 
Introduction 
1.1 A overview of protein synthesis 
Within living organisms, proteins play crucial roles in catalyzing metabolic 
reactions, transporting molecules, responding to environmental stimuli, and 
maintaining cellular structure etc. Therefore, protein synthesis is one of the most 
important cellular processes. Translation of messenger RNAs (mRNAs) into 
proteins consists of three subprocesses: initiation, elongation and termination. In 
eukaryotes, translation initiates with the assembly of the 43S preinitiation complex 
(PIC), which contains the small ribosomal subunit carrying the initiator transfer 
RNA (tRNA) in its P-site and several initiation factors (IFs). Subsequently, the 
43S PIC binds to the 5’ cap-proximal region of the mRNA and scans the whole 
5’ untranslated region (5’ UTR) for the AUG start codon. After the start codon 
identification, the large ribosomal subunit joins and the translation elongation 
competent ribosome is formed. To efficient and accurate assemble this 80S ribosome 
with initiator tRNA complemented with the mRNA start codon in its P-site, up to a 
dozen of initiation factors are required. In the decoding stage of the elongation cycle, 
an aminoacyl-tRNA coupled with an elongation factor (i.e. eEF1A) binds to the 
mRNA codon in the A-site through its complementary anticodon. Then, the peptide 
chain on the P-site tRNA is transferred to the aminoacyl group in the A site tRNA. 
In the next steps, the ribosome moves towards the 3’ end of the mRNA by one codon 
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with the help of eEF2, resulting in the translocation of the P-site deacylated tRNA 
and A-site peptidyl tRNA to the E-site and P-site, respectively. This elongation 
reaction cycle continues until the stop codon is reached. The termination codon is 
recognized by translation release factors (RFs). On binding to the corresponding 
stop codon, release factors induce the release of the newly synthesized polypeptide. 
Ribosome subunits as well as translation auxiliary protein factors are recycled for 
further rounds of translation.  
1.2 Eukaryotic translation initiation and the role 
of initiation factors 
Translation initiation in eukaryotes requires the assistance of at least 12 different 
accessory protein factors, the so-called eukaryotic initiation factors (eIFs), which are 
summarized in Table 1.1. As outlined in Figure 1.1, the eukaryotic translation 
initiation pathway via scanning mechanism can be divided into several steps.  
Formation of 43S preinitiation complex   Eukaryotic translation 
initiation commences with the binding of the initiator tRNA (Met-tRNAiMet), in a 
complex with GTP-bound eIF2, to the P-site of the 40S ribosomal subunit. This step 
is promoted by eIF3 complex, eIF5, 1 and 1A, which further form the 43S 
preinitiation complex (43S PIC) with the eIF2·GTP·Met-tRNAiMet ternary complex 
(TC) and the 40S subunit [1-3]. More and more evidence has emerged that eIF1, 3, 5 
and the TC interact with each other prior to associating with the 40S subunit, 
forming a multi-factor complex (MFC) [4-6]. Interactions among the MFC are 
known to enhance the assembly and stability of the 43S PIC [4,6]. 
Recruitment of 43S PIC to mRNA   The 43S PIC is recruited to the 5’ end 
region of the mRNA, in which the heterotrimeric complex eIF4F plays important 
roles [7,8]. eIF4F consists of the mRNA cap recognition protein eIF4E, the 
DEAD-box RNA helicase eIF4A as well as the scaffolding protein eIF4G. eIF4A is 
known to unwind duplex structures in the 5’ UTR of the mRNA to facilitate the 
recruitment of the 43S PIC and subsequent scanning. eIF4G contains binding sites  
Introduction 
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Table 1.1: Eukaryotic initiation factors  
Name Number &  
mass (kDa) of 
subunits  
Functions 
eIF1 1 (13) Ensures to select the correct initiation codon; facilitates ribosomal 
scanning; prevents premature hydrolysis of eIF2-bound GTP and Pi 
release; promotes the recruitment of eIF2·GTP·Met-tRNAiMet 
ternary complex (TC) to the 40S subunit 
eIF1A 1 (17) Promotes binding of the TC to the 40S subunit; mediates ribosomal 
scanning and start codon recognition 
eIF2 3 (36, 38 and 51) Binds to GTP and the initiator tRNA (Met-tRNAiMet), stimulating the 
recruitment of Met-tRNAiMet to the 40S subunit  
eIF3 13 (800 total) Interacts with the 40S subunit and initiation factors 1, 4 and 5; 
promotes the recruitment of the TC to the 40S subunit; involved in 
attachment of the 43S preiniation complex (PIC) to mRNA and 
subsequent scanning; and participates in post-termination of 
translation and prevents ribosomal subunits re-joining  
eIF4E 1 (24) Binds to the m7G ‘cap’ structure of mRNA 
eIF4A 1 (46) DEAD-box RNA helicase and also possesses ATPase activity, 
unwinding the secondary structures in the 5′ UTR of the mRNA 
eIF4G 1 (176) Multi-scaffold protein, interacting with eIF4E, eIF4A, PABP, eIF3, 
MNK1 and RNA; also possesses the ability to enhances the activities 
of elF4A 
eIF4B 1 (69) Enhances the activities of eIF4A 
eIF4H 1 (27) Stimulates the activities of eIF4A and is homologous to the 
N-terminal domain of eIF4B 
eIF5 1 (49) The GTPase-activating protein (GAP) of GTP-bound eIF2, inducing 
hydrolysis of eIF2-bound GTP 
eIF5B 1 (139) A ribosome-dependent GTPase that mediates the joining of the 60S 
subunit 
eIF2B 5 (34, 39, 50, 60 
and 80) 
A guanine nucleotide exchange factor (GEF), promoting change of 
GDP to GTP on eIF2 
The molecular mass, which gives a rough ideal about the size of the proteins, was calculated from human 
initiation factors.  
for eIF4E, eIF4A, poly(A)-binding protein (PABP), RNA, and in mammals for eIF3 
as well as the eIF4E kinase MNK1 [9-13]. The binding sites for eIF4E, PABP and 
RNA in eIF4G enable the formation of the stable circular cap·eIF4E·eIF4G·PABP· 
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poly(A)-tail messenger ribonucleoprotein particle (mRNP) [8]. The eIF4G-eIF3 
protein interaction (eIF4G-eIF5 in yeast) is thought to bridge the activated mRNP 
and the 43S PIC [12,14]. Notably, eIF3 complex and the 40S itself also possess 
RNA-binding activity, which could contribute to the attachment of the 43S PIC to 
the mRNA [15,16].  
Scanning of the mRNA 5’ UTR   Once attached to the vicinity of the mRNA 
cap, the 43S PIC scans the downstream of the cap for the correct AUG start codon. 
The ribosomal movement along the mRNA requires unwinding of duplexes in the 
5’ UTR and a scanning-competent conformation of the 40S itself. This ribosomal 
conformation is induced by two small initiation factors, eIF1 and eIF1A [17,18]. 
eIF1 binds to the 40S subunit close to the P-site and strictly monitors the scanning 
for an AUG codon in an optimal sequence context (GCC(A/G)CCAUGG) [19,20]. The 
universally conserved eIF1A is situated at the ribosomal A-site with its compact 
oligonuleotide binding domain (OB domain). This ribosomal situation of eIF1A 
prevents tRNAs from accessing the A-site during initiation phase. In addition, 
eIF1A bridges the head and the body of the 40S subunit through an α-helix and the 
long unstructured N-terminal tail (NTT) [21,22]. Connection between the ribosomal 
head and body generates an active 40S subunit with closed mRNA channel around 
the A-site, which would hold the incoming mRNA and promote the scanning.  
The single-stranded mRNA regions are generated by ATP-dependent RNA 
helicases and their auxiliary factors. eIF4A, eIF4G and eIF4B as well as ATP are 
needed even in the scanning of 5’ UTRs that contains weak secondary structures 
[18,23]. In addition to eIF4A, other RNA helicases (e.g. human DHX29, DDX3, yeast 
Ded1) have been shown to be involved in scanning, especially in long and highly 
structured 5’ UTRs [24-27].  
Start codon selection   eIF1 plays a crucial role in stringent recognition of 
the correct start codon that is usually the first AUG triplet in a suitable context 
(GCC(A/G)CCAUGG) [28,29]. eIF1 is positioned on the top of the 18S rRNA helix 44 
and would sterically clash with the anti-codon stem loop (ASL) in the P-site and 
with the D-loop of the initiator tRNA [20,30]. The special localization and high 
affinity to the TC bound 40S subunit (with a Kd ~1.4 nM [17]) of eIF1 ensure the  
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Figure 1.1: Overview of eukaryotic translation initiation via scanning. The process of initiation begins 
with the assembly of the 43S preinitiation complex (PIC), which contains the 40S ribosomal subunit with 
initiator tRNA in its P-site and initiation factors 1, 1A, 2, 3 and 5. mRNA is activated by the binding of 
eIF4E to the m7G cap of the mRNA, accompanied with unwinding the duplexes in the 5’ UTR by eIF4A, 
and interaction of PABP with the mRNA poly(A) tail. The ATP-dependent helicase activity of eIF4A is 
facilitated by eIF4B and eIF4G. The 43S PIC attaches to the 5′ end of the activated mRNA and scans the 
mRNA 5′ UTR of which the secondary structures are melted by eIF4A and other helicases. Once the 
AUG start codon base pairs with the anticodon of Met-tRNAiMet, hydrolysis of eIF2-bound GTP triggers 
dissociation of initiation factors from the 40S subunit. Subsequently, eIF2-GDP is released from the 
initiator tRNA, and GTP bound eIF5B takes participate in the joining of the 60S subunit, forming the 
elongation competent 80S ribosome. This figure is modified from Jackson et al., 2010 [31]. 
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discrimination against non-AUG triplets as well as AUG in non-optimal context, 
and trigger the dissociation of the ribosomal complex aberrantly assembled at such 
triplets. Establishment of the AUG codon-anticodon base pairing, which 
significantly increases the affinity of TC to the 40S subunit (Kd <1 nM), displaces 
eIF1 from near the P-site [32,33]. Subsequently, the 40S rotates its head domain 
and locks the initiator tRNA in a stable P-site state. The NTT and CTT of eIF1A 
both reach into the ribosomal P-site and would also participate in the start codon 
selection [34].  
Dissociation of initiation factors and joining of the 60S ribosomal 
subunit   The displacement of eIF1 (probably partially) upon AUG recognition 
triggers the irreversible eIF5-stimulated GTP hydrolysis by eIF2 in the TC [35]. 
GTP hydrolysis induces a conformational change of eIF2 and reduces its affinity for 
the initiator tRNA [36]. The Met-tRNAiMet unbound eIF2-GDP eventually 
dissociates from the 40S subunit and is recharged with GTP for another cycle of 
initiation. Recharging eIF2 with GTP is mediated by its guanine nucleotide 
exchange factor (GEF) eIF2B [37]. Joining of the 60S subunit and complete 
dissociation of initiation factors bound to the 40S interface from the 40S subunit are 
mediated by the ribosome-dependent GTPase eIF5B [38,39]. eIF5B is situated in 
the intersubunit cleft and extensively contacts with both ribosomal subunits and 
the initiator tRNA, which enables it to promote the formation of the 
elongation-competent 80S ribosome [40,41]. The release of eIF5B is mediated 
through the GTP hydrolysis by its own. Those initiation factors that bind to the 
solvent exposed side of the 40S subunit (e.g. eIF4G and eIF3) could delay their 
dissociation from the 40S ribosomal subunit [31].  
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1.3 Eukaryotic translation initiation factor 3  
1.3.1 Composition and interaction network of eIF3  
Among the dozen of initiation factors, eIF3 is the largest multi-subunit complex. In 
mammals, it consists of 13 nonidentical subunits (designated eIF3a-m). However, 
not all but only five of eIF3 subunits (a/Tig32, b/Prt1, c/Nip1, g/Tif35 and i/Tif34) are 
conserved in all organisms and are crucial for translation in vivo [42-44]. These five 
subunits form a functional ‘core’ of eIF3 and thus represent the simplest model for 
structural and functional investigations. In this thesis, a main focus will be put on 
the eIF3 core, of which the subunits are outlined in more details in Figure 1.2. 
Consistent with its complex composition, eIF3 generates an elaborate 
subunit-subunit interaction web. Within the core eIF3, the b subunit (eIF3b) serves 
as the major scaffold protein, providing interaction platforms for other subunits 
[4,45]. The ~90 kDa eIF3b contains an N-terminal structurally canonical RNA 
recognition motif (RRM), a middle WD40 domain, which has been predicted to fold 
into two tandem β-propellers, and a following C-terminal domain (CTD) [46,47]. 
eIF3b is able to associate with the CTD of eIF3a and the N-terminal domain (NTD) 
of eIF3j through its NTD, while eIF3b-CTD is required for the interaction of eIF3g 
and eIF3i subunits [4,45,47,48]. The pivotal role of eIF3b as a versatile interaction 
partner is further emphasized by studies in mammalian cells, which indicate a 
function in tumour growth, identifying eIF3b as a potential therapeutic drug target 
[49-51]. So far, the structural information about eIF3b is limited to the RRM 
domain (~100 amino acids) and a ~40 residue α-helix of the CTD [47,48,52]. In 
contrast, neither functional nor structural information is available for the central 
WD40 repeats, which form ~65% of the protein and are highly conserved from yeast 
to humans. 
eIF3a is the largest subunit of eIF3 and consists of ~1000-1400 amino acid 
residues from yeast to humans. Up to now, only a PCI domain of eIF3a is well 
defined [53]. PCI domains are known to play roles in the 26S proteasome lid, COP9 
signalosome (CSN) and eukaryotic initiation factor 3 by serving as a principal 
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Figure 1.2: Overview of eIF3 functional core subunits, including structures of domains in cartoon 
representation. The green α-helix bound to eIF3i (yellow) is from eIF3b-CTD (residues 700-738). The 
boundaries of the domains are indicated for S. cerevisia eIF3a and c, and for C. thermophilum eIF3b, i 
and g.  
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scaffold [54]. The PCI domain of eIF3a is located at the NTD and is proposed to 
interact with the ribosomal protein S0 (rpS0) located in the vicinity of the mRNA 
exit pore [1,55]. The structure of eIF3a PCI domain was recently solved by 
Khoshnevis et al. [53]. They also demonstrated that this domain mediates the 
binding of eIF3a to eIF3c and is indispensable (but not sufficient) for interacting 
with RNA. In addition, eIF3a contains a region that is related in sequence to eIF3j, 
called HCR1 (a yeast homolog of human eIF3j) like domain (HLD). The HLD 
domain of eIF3a is thought to associate with eIF3b [4]. The eIF3a-CTD was reported 
to interact with rpS2e, rpS3e, as well as helices 16-18 of the 18S rRNA, all 
constituents of the mRNA entry channel [1,15,30]. 
eIF3c is a ~100 kDa protein and contains a PCI domain at the extreme CTD, 
which was reported to directly interact with the seven-bladed WD40 β-propeller 
ribosomal protein ASC1, a yeast homolog of human RACK1 [56]. The PCI domain of 
eIF3c is the first example that exhibits strong but unspecific RNA binding ability, 
apart from the interaction with protein [56]. The 3 dimensional (3D) structure of 
eIF3c’s PCI domain was modeled in silico [56]. The NTD of eIF3c is thought to 
interact with eIF3a, eIF1 and eIF5 [57]. 
eIF3g and eIF3i are two small proteins with molecular mass of ~35 kDa each. 
eIF3g contains a predicted Zn-finger domain in its NTD and an RRM in its CTD. 
eIF3g-NTD has been reported to mediate the association with eIF3b and eIF3i, 
while the C-terminal RRM is necessary for interacting with 18S rRNA of 40S [4,44]. 
Additionally, eIF3g has been reported to bind to rpS3e and rpS20e [58]. The 
structure of eIF3g-RRM was determined by NMR and reveals a canonical βαββαβ 
fold (PDB code: 2CQ0). eIF3i adopts a seven-bladed WD40 β-propeller architecture 
and interacts with eIF3b-CTD via the bottom side of the propeller [48]. eIF3i is also 
able to bind eIF3g, however, the binding site is not known yet [59]. 
1.3.2 The role of eIF3 in translation initiation  
The structural complexity provides a prerequisite for crucial involvement of eIF3 in 
almost all translation initiation steps.  
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Promoting the assembly of 43S PIC   eIF3 binds to eIF2β-NTD, and thus 
to eIF2·GTP·Met-tRNAiMet ternary complex, through its subunit a (eIF3a) [42]. In 
addition, it interacts with eIF1 and eIF5-CTD via the c subunit (eIF3c) [57,60]. 
Yeast, plant and human eIF3, 1, 5 and the TC have been demonstrated in 
succession to form a multifactor complex (MFC) (free of the 40S ribosomal subunit), 
which can be isolated from whole cell extracts (Figure 1.3) [5,6,57]. The formation of 
MFC could facilitate the cooperative binding of these initiation factors to the 40S 
subunit, generating the 43S preinitiation complex (PIC). eIF3 plays an important 
role in the assembly of the 43S PIC. Besides interacting with eIF1, 5 and the TC, 
eIF3 makes extensive contacts with the small ribosomal subunit. The NTD of eIF3a 
binds to the ribosomal protein rpS0 and rpS1e, while eIF3a-CTD forms 
intermolecular bridges with rpS2e, rpS3e as well as the helices 16-18 of 18S RNA 
[1,15,55,61,62]. The c subunit also directly interacts with ribosome via the 
association with RACK1 [56]. The interaction between eIF3b and the 40S subunit is 
mediated by another eIF3 subunit, eIF3j [47]. The small subunits g and i also 
function in recruiting initiation factors to the ribosome. eIF3g is anchored in the 
‘beak’ region of 40S, involving ribosomal proteins rpS3e and rpS20e [58]. A mutant 
with deletion of eIF3g and i showed lower 40S binding affinity. The ribosomal 
association of eIF3 has also been determined by cryo-electron microscopy (cryo-EM) 
reconstitutions [61,63]. Consistent with biochemical investigations, the cryo-EM 
structures of eIF3 bound to the 40S ribosomal subunit reveal eIF3 on the 
solvent-exposed side of the 40S. 
Functioning in mRNA attachment   Mammalian eIF3 facilitates the 
recruitment of mRNA to the 40S subunit in vitro [42]. A mutation in yeast eIF3b as 
well as mutants with deletion of eIF3a and eIF3b impair mRNA binding to the 40S 
subunit in vivo [64,65]. Direct interaction of mammalian eIF3 with eIF4G, a scaffold 
subunit of the mRNA activation complex eIF4F, would enable eIF3 to function as a 
‘bridge’ between the 40S subunit and the eIF4F-mRNA complex [14,66]. However, 
this eIF3-eIF4G interaction is not universally conserved. For example, yeast eIF4G 
lacks the eIF3-binding domain and thus is unable to interact with eIF3, which 
indicates that eIF3 can facilitate mRNA binding to the 40S independently of eIF4G.  
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Figure 1.3: Schematic representation of the multifactor complex (MFC). Depicted interactions are based 
on biochemical investigations. 
Indeed, a yeast mutant lacking eIF4G led to accumulation, rather than depletion, of 
mRNAs in the native 48S PICs [65]. eIF4B might also serve as an adaptor between 
mRNA and eIF3, since mammalian and yeast eIF4B have been demonstrated to 
interact with eIF3a and eIF3g, respectively [67,68]. In addition, recent evidences 
showed that eIF3 could directly bind to mRNAs and promote their attachment to 
and/or stabilize their binding on the 40S subunit [42,53,56]. 
Involvement in scanning and AUG start codon recognition.  eIF1 is the 
gatekeeper of the start codon identification, while eIF5 triggers the GTP hydrolysis 
by TC upon the start codon recognition. eIF3 is able to cooperatively interact with 
eIF1 and 5 through its c subunit’s NTD [69]. Mutations in yeast eIF3c-NTD 
stimulate translation initiation at UUG codons in vivo [69]. The major scaffold 
subunit of eIF3, eIF3b, is believed to be involved in this process as well. Mutation 
within eIF3b-RRM increases leaky scanning, which indicates a role of eIF3b in AUG 
initiation selection. Strong leaky scanning is also observed if the NTD of eIF3j is 
deleted [42]. All these findings strongly suggest that the multi-subunit eIF3 
remains bound to the ribosome after mRNA recruitment and participates in 
scanning and start codon recognition. 
In addition to playing role in translation initiation, eIF3 is also involved in 
post-termination of proteins synthesis, promoting dissociation and preventing 
re-joining of ribosomal subunits. For comprehensive review see [42]. 
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1.4 Eukaryotic translation initiation factor 4  
The multi-subunit eukaryotic translation initiation factor 4 cooperatively functions 
in the activation of the mRNA to be translated and the subsequent scanning. It 
includes the 7-methyl guanosine triphosphate (m7GTP) cap recognition protein 
eIF4E, the ATP-dependent RNA helicase eIF4A, eIF4A auxiliary proteins eIF4B 
and eIF4H (in mammalian cells), as well as the large scaffold protein eIF4G. eIF4E, 
eIF4G and eIF4A form the heterotrimeric complex eIF4F.  
1.4.1 eIF4E  
eIF4E is a ~24 kDa protein and was firstly identified in 1978 by its ability to 
specifically cross-link to the 5’-terminal cap (m7GTP) in the mRNAs [70]. It binds 
the cap so strongly that it can be purified to apparent homogeneity by one affinity 
chromatography on an m7GDP-coupled matrix [71]. eIF4E recognizes the cap 
structure of the mRNA and thus is crucial for cap-dependent translation. Depletion 
of eIF4E significantly reduces translation of capped mRNA and this reduction can 
be restored by addition of purified eIF4E [72]. eIF4E is universally conserved (with 
at least 30% sequence identity) and mammalian eIF4E can rescue the yeast 
lethality caused by mutation of yeast eIF4E gene, CDC33 [73]. 
eIF4E Structure  The three-dimensional structure of eIF4E has been 
extensively investigated by X-ray crystallography and nuclear magnetic resonance 
(NMR). So far, up to 30 eIF4E structures from different organisms either in apo, 
m7GDP- or m7GTP-bound states or in complex with inhibitors or eIF4E-binding 
proteins are present in PDB database. These proteins adopt the same overall 
baseball glove-like architecture, consisting of one single α/β  domain (Figure 1.4) 
[74,75]. The eight antiparallel β-strands form the ‘palm’ side of the structure, while 
the α-helices situate as the back convex surface. eIF4E orthologs across yeast to 
human utilize almost identical modes of cap binding. The m7GTP cap or the cap 
analog m7GDP is captured on the concave palm surface of eIF4E by π-π stacking and 
cation-π interactions, hydrogen bonds, salt bridges as well as a van der Waals 
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contact (Figure 1.4). All of the residues that are involved in the cap-binding are 




Figure 1.4: Structure of eIF4E (green and light cyan) bound to the cap analog m7GDP (yellow and 
orange) (PDB code: 1EJ1). (A) Schematic domain organization of eIF4E. (B) Overall structure. The cap 
is held in the concave side. (C) Magnified view of the cap-binding area. The amino acid side chains 
involved in the interaction are highlighted and shown in sticks. 
1.4.2 eIF4A  
The initiation factor eIF4A (~45 kDa) is thought to be the ‘godfather’ of the 
DEAD-box family of ATP-dependent RNA helicases [76,77]. This family is named 
after its conserved Asp-Glu-Ala-Asp (DEAD) sequence motif in which the first Asp 
coordinates a magnesium ion and the Glu functions in activation of the catalytic 
water molecule to hydrolyze the γ phosphate of the ATP [78]. In addition to 
exhibiting the RNA unwinding activity, DEAD-box helicases also possess 
RNA-dependent ATPase activity [79]. The ATP and RNA binding, ATP hydrolysis 
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as well as RNA unwinding motifs are highly conserved in all helicases from this 
family. These conserved motifs are arranged into two recA-like domains, which, in 
many other DEAD-box proteins, are flanked by N- and/or C-terminal domains that 
would facilitate substrate binding [80-82]. eIF4A contains only the two core 
recA-like domains, lacking any accessory domain. However, other initiation factors 
that are able to enhance the activities of eIF4A (e.g. eIF4G and eIF4B) may play 
some of the same roles.  
The highly conserved functional motifs in DEAD-box containing helicases are 
outlined in Figure 1.5. Their relative sequential positions (shown for Saccharomyces  
 
 
Figure 1.5: Conserved functional DEAD-box helicase motifs in sceIF4A. (A) The 3D structure of eIF4A 
bound RNA and AMPPNP is modeled based on the crystal structure of eIF4A III (2HYI). (B) Schematic 
functional motif organization of eIF4A. Residues directly involved in ATP and RNA binding, ATP 
hydrolysis as well as RNA unwinding are depicted as spheres in (A) and small circles in (B), respectively. 
Small circles in (B): blue: RNA binding and unwinding; black: ATP binding; pink: coordinating a 
magnesium ion; green: activating the catalytic water; orange: stabilizing the transition state 
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cerevisiae eIF4A) and localizations on a 3D structural model of sceIF4A are shown 
in the bottom and top panel, respectively. The 3D model is made based on the 
crystal structure of the related protein eIF4A III (PDB code: 2HYI), which plays role 
in RNA processing, but not in translation initiation [83,84]. The bound RNA (orange) 
and ATP analog AMPPNP (hotpink) in this model are taken directly from eIF4A III 
structure. The N-terminal domain of eIF4A (also other DEAD-box proteins) harbors 
the eponymous DEAD segment and most of motifs involved in the ATP binding and 
hydrolysis, including Q, I, II, and III. eIF4A-NTD also contains RNA binding and 
unwinding motifs Ia, Ib and Ic. The smaller CTD contains motifs IV, IVa and V, 
which are implicated in RNA binding or in helicase activity, and motifs VI 
responsible for binding ATP [80]. Although these conserved functioning fragments 
are distributed throughout the whole eIF4A sequence, they are all localized at the 
interface between the two RecA-like domains as revealed by the modeled structure. 
    The activities of DEAD-box helicases are based on conformational changes. In 
the absence of ATP and RNA, the two recA-like domains are far apart, forming an 
‘open’ conformation. By contrast, when ATP and RNA are present, the two core 
domains move together, assembling the ‘closed’ conformation, to cooperatively 
hydrolyze ATP and to unwind the double-stranded RNA. So far, there is no crystal 
structure of eIF4A in its closed form. But the structures of yeast eIF4A in the apo 
state (Figure 1.6 A) and in complex with a HEAT repeat domain of eIF4G 
(eIF4G572-853) (Figure 1.6 B) have been crystallographically determined [85,86]. 
Compared to the known structures of other DEAD-box proteins in their closed 
conformations with bound RNA and nucleotide (e.g. human eIF4A III and 
drosophila VASA), the structure of yeast eIF4A/eIF4G572-853 shows a ‘half open’ 
conformation of eIF4A, in which the functional motifs are pre-organized for 
activation. 
eIF4A itself shows very low ATPase and helicase activities. However, the ATP 
hydrolysis and RNA unwinding efficiency are significantly stimulated by eIF4B, 
eIF4H and eIF4G [79,87,88]. It has been proposed that these auxiliary proteins 
enhance the activities of eIF4A by promoting a closed and more active state of the 
helicase (Figure 1.6 C). However, the underlying mechanism is still elusive.  
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Figure 1.6: Conformational changes of eIF4A. Crystal structures of yeast eIF4A in its open (1FUU) (A) 
and half open (2VSO) (B) conformations. A modeled structure of the closed state of S. cerevisiae eIF4A 
(based on human eIF4A III (2HYI)) is provided (C). During modeling, eIF4A-CTD, which is the 
primary eIF4G-interacting domain, is fixed, while the NTD of eIF4A is moved and superimposed onto 
eIF4A III-NTD. 
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1.4.3 eIF4B and eIF4H 
eIF4B (~50 kDa) plays an auxiliary, but not essential role in translation initiation 
because the 48S preinitiation complex (48S PIC) can be assembled in its absence 
and a yeast strain with deletion of eIF4B gene, TIF3, is viable [89,90]. Experiments 
have shown that eIF4B enhances the duplex unwinding activity and ATPase 
activity of eIF4A [87,88]. However, the underlying mechanism of the enhancement 
is unclear. The sequences of eIF4B orthologs differ a lot, with identities of 20-30% 
across species. Mammalian eIF4B forms a homodimer via the middle seven repeats 
that are rich in aspartic acid, arginine, tyrosine and glycine rich (termed DRYG 
domain), which also mediate the interaction of eIF4B with eIF3 [91,92]. The DRYG 
domain is missing in yeast eIF4B. In addition, eIF4B possesses two RNA-binding 
domains. The canonical RNA recognition motif (RRM) localized in the N-terminus is 
thought to bind to the 18S rRNA, whereas the C-terminal basic region rich in 
arginine and serine residues strongly interacts with any RNAs in a 
sequence-independent manner [67,93,94]. Up to now, a solution structure of the 
RRM domain, which employs a typical βαββαβ fold, is the only known structural 
information of eIF4B (PDB code: 2J76) [95].  
 
     
eIF4H (~25 kDa) was discovered based on its stimulatory ability to an in vitro 
translation [96]. This protein exhibits a sequence homology to the N-terminal region 
of eIF4B that contains the first RRM domain but not the DRYG repeats nor the 
second RNA-binding basic domain. eIF4H enhance activities of eIF4A but cannot 
completely substitute for eIF4B [88,96]. In yeast cells, an eIF4H homolog is missing.  
Figure 1.7: Solution 
structure of human 
eIF4B-RRM domain, 
displaying a canonical 
βαββαβ folding. 	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1.4.4 eIF4G  
The translation initiation factor 4G (eIF4G) is a multifactor binding protein at the 
center of eIF4F complex and is vital in both cap-dependent and IRES-driven 
translation [9]. This protein has been conceptually divided into three parts based on 
the products of picornaviral protease cleavage [9]: The N-terminal third is the most 
variable and flexible part of eIF4G, containing a binding site for the poly(A)-binding 
protein (PABP), as well as one for the cap-binding protein eIF4E [9,75,97,98]. The 
middle third of eIF4G associates with the RNA helicase eIF4A and in mammals 
with eIF3, which directly binds to the ribosome [11,12,14,86]. The C-terminal third, 
which is missing in yeast eIF4G, contains the second eIF4A binding site and a 
binding site for the eIF4E kinase MNK1 [11,13,99]. The first two thirds of eIF4G 
have been identified as crucial for cap-dependent translation, whereas the last third 
is not required for translation and only plays some modulatory roles [99,100]. In 
addition to binding sites for proteins, eIF4G also possesses a conserved 
RNA-binding region firstly noted in yeast eIF4G [101]. These properties of eIF4G 
are the basis for its two main functions: mRNA circularization and ribosome 
recruitment.  
PABP-binding site   The interaction between eIF4G and PABP has been 
determined to be necessary for the stimulation of mRNA translation [102]. eIF4G 
binds the RRM2 of PABP, which contains four RNA recognition motifs (RRM1-4) 
and a C-terminal MLLE domain, through a ~25-residue fragment in its N-terminus 
(residues 178-203 in human eIF4G) as shown by both NMR and crystal structure. 
The binding of PABP induces a conformational change of eIF4G from an 
unstructured form to a folded stated (Figure 1.8) [98].  
eIF4E-binding site  eIF4E-binding site on eIF4G is the first best 
characterized polypeptide-binding site. eIF4G utilizes the conserved Y-X-X-X-X-L-Φ 
motif (where X is variable and Φ represents hydrophobic) to recognize eIF4E [103]. 
This segment is also present in a family of translational repressors, the 
eIF4E-binding proteins (4E-BPs), which compete with eIF4G to bind eIF4E (see 
Section 1.5). NMR and crystal structures show that the eIF4G fragment interacts 
with the dorsal convex surface of eIF4E, behind the cap-binding groove [75,103]. 
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Figure 1.8: Overall information of eIF4G. (A) Schematic domain organization of S. cerevisiae eIF4G. 
The boundaries of the domains are indicated. RNA-BR: RNA binding region; PABP-BR: PABP binding 
region; 4E-BR: eIF4A binding region; 4A-BD: eIF4A binding domain. (B) The known domain structures 
of eIF4G in complex with PABP (pale-blue, left), eIF4E (green, middle) and eIF4A (cyan and blue, 
right), respectively. h: human; y: yeast. 
eIF4A-binding site  The eIF4A-binding region of eIF4G forms a HEAT 
repeat domain, with helically stacked α-helical hairpins (Figure 1.8) [86]. There is 
only one 4A-binding site in yeast eIF4G, but two in mammalian. Binding of eIF4A to 
eIF4G is not as strong as that of eIF4E to eIF4G (a Kd of ~10 nM) [104]. eIF4A can 
be readily dissociated from eIF4G on ion exchange columns and natively purified 
eIF4F complexes usually lack eIF4A [105-107]. The structure of yeast 
eIF4A/eIF4G-M complex (where eIF4G only contains the 4A-binding domain) has 
also been solved [86]. eIF4G associates with both recA-like domains of eIF4A, but 
primarily with the C-terminal recA-like domain. This interaction triggers eIF4A to 
adopt a half open conformation that is thought to be correlated with the stimulation 
of eIF4A activities [108].  
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RNA-binding site   Yeast eIF4G contains three regions that are rich in basic 
amino acids. These three basic clusters are located in the N-, middle and C-terminal 
domain of eIF4G, respectively, and are able to bind RNA [109,110]. Deletion of each 
one individually still allows for tight binding of eIF4G to RNA. It has been shown 
that the three RNA binding fragments of eIF4G cooperatively stimulate RNA 
unwinding by eIF4A in the 5’ to 3’ direction [110]. Like its yeast counterpart, human 
eIF4G also contains RNA-binding fragments. However, it does not show a 
preference to 5’-overhangs, indicating that this mechanism is not universal.  
1.5 Translational control via eIF4F 
Translational control in eukaryotic cells is critical for regulating gene expression. 
Compared to regulation at the point of transcription, translational control of 
existing mRNAs allows for more rapid response to environmental changes. 
Controlling translational rates at initiation phase rather than elongation or 
termination makes the regulation particularly effective, thus initiation is the most 
regulated and the rate-limiting stage of protein synthesis. Two general types of 
regulation occur at translational initiation phase: by mechanisms which influence 
initiation factors (eIFs) or the mRNA itself either through specific RNA-binding 
proteins or via microRNAs. The best-understood instances in the eIFs-dependent 
regulation are control of the availability of translational active eIF2 and eIF4F by 
phosphorylation. eIF3 and eIF4B are also phosphorylated under certain conditions, 
which may alter their activities [31]. However, not much is known about this 
regulation. In this section the translational regulation via eIF4F (a main focus of 
this thesis) will be described in detail.  
1.5.1 eIF4E regulation  
eIF4E can be phosphorylated in vivo [7,111]. The phosphorylation of eIF4E is 
catalyzed by mitogen-activated protein kinase (MAPK)-interacting serine/threonine 
kinase 1 (Mnk1), which directly binds to eIF4G in mammalian cells [112]. It has 
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been reported that phosphorylated eIF4E exhibits up to fourfold stronger affinity for 
the cap analogs m7GTP and m7GpppG, as well as for capped mRNA than its 
nonphosphorylated counterpart [113]. eIF4E phosphorylation has been shown to 
promote translational upregulation of several proteins that are implicated in  
tumorigenesis [7]. 
In addition, eIF4E activity is also regulated through its association with a 
family of repressor proteins, eIF4E-binding proteins (4E-Bps). 4E-Bps (~10 to 12 
kDa) inhibit cap-dependent (but not cap-independent) translation, both in cell-free 
translation assays and when overexpressed in cells [114]. Binding of 4E-BPs to 
eIF4E does not affect eIF4E affinity for the mRNA cap. Instead, 4E-BPs prevents 
the interaction of eIF4E with eIF4G, thus suppressing the formation of the mRNA 
activation complex eIF4F. Both eIF4G and 4E-BPs contains the Y-X-X-X-X-L-Φ 
motif (where X is any amino acid and Φ is a hydrophobic residue) that is the binding 
site for eIF4E, and compete for interaction with eIF4E. 4E-BPs and eIF4G do bind 
the same region on eIF4E as revealed by the crystal structures of eIF4E in complex 
with a fragment of 4E-BPs or eIF4G [103].  
Binding of 4E-BPs to eIF4E is modulated by 4E-BPs phosphorylation. 
Superphosphorylated 4E-BPs, which is induced by extracellular stimuli (including 
hormones, growth factors, cytokines, mitogens, etc.), exhibit lower affinity to eIF4E. 
In contrast, under stress conditions (e.g. starvation or infection with poliovirus), the 
phosphorylation of eIF4E is decreased, resulting in efficient binding to eIF4E and 
thus reduction of protein expression. 
1.5.2 eIF4A regulation  
eIF4A is also an important target for regulation. The tumor suppressor protein, 
programmed cell death 4 (PDCD4), has been demonstrated to inhibit translation by 
interacting with eIF4A [115]. The structure of eIF4A-PDCD4 complex has been 
determined, revealing that one PDCD4 molecule binds two eIF4A molecules, traps 
eIF4A in an inactive conformation and prevents the interaction of eIF4A with 
eIF4G to restrain the formation of the enzymatic active eIF4F complex [116,117]. In 
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addition, several studies have reported that two natural products, hippuristanol 
and pateamine A, inhibit translation initiation through directly modulating eIF4A 
activity [118-120]. Moreover, the non-coding RNA BC1 specifically binds to eIF4A 
and promotes the RNA-dependent ATPase activity of eIF4A but block its RNA 
separation activity, and thus inhibits translation initiation in neurons [121]. 
1.5.3 eIF4G regulation  
eIF4G is phosphorylated in response to various stimuli [122-125]. Increased 
phosphorylation of eIF4G is correlated with an increase in the formation of eIF4F 
complex, indicating that eIF4G phosphorylation regulates the level of eIF4F [126]. 
The eIF4F concentration is also impaired by an eIF4G structural homolog, 
death-associated protein 5 (DAP5, also called p97). DAP5 shares ~30 identity with 
C-terminal two thirds of eIF4G but lacks the N-terminal eIF4E and PABP binding 
sites. It competitively interacts with eIF4A (and eIF3) and promotes the 
IRES-driven translation, but prevents the cap-dependent translation [127-129]. 
Similar inhibition of cap-dependent translation occurs under certain stressful 
conditions, for example, viral infection or apoptosis. eIF4G is proteolytically cleaved 
into two or more fragments, resulting in an eIF4F-complex lacking eIF4E (and thus 
the cap-recognition component) [7,130].  
1.6 Aims of this thesis 
Despite the extensive and crucial involvement of the multi-subunit eIF3 complex in 
translation initiation (43S PIC assembly, mRNA recruitment, scanning and start 
codon selection), its overall structure is limited to the low-resolution cryo-EM 
reconstructions [61,63]. In addition, only several structures of domains of eIF3 
subunits (the RRM domain of eIF3b and eIF3g, the PCI domain of eIF3a and eIF3k) 
and of the seven-bladed β-propeller protein eIF3i have been determined at atomic 
level either by X-ray crystallography or NMR [47,48,52,53,131]. However, in order 
to understand the mechanism by which eIF3 works in translation initiation more 
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high-resolution structures of eIF3 complex, subcomplexes or domains are needed. 
Hence, a major goal of this thesis is to establish strategies for reconstitution of eIF3 
subcomplexes in vitro, as well as obtain crystals of these complexes and individual 
subunits. Proteins from different organisms are chosen as the targets of interest. 
Promising crystallizable subcomplexes of eIF3 and subunit variants are 
systematically designed and screened. 
Although structural information about eIF4E- and eIF4A-binding domain of 
eIF4G in complex with eIF4E and eIF4A, respectively, are available, the molecular 
organization in eIF4F subunits is still elusive. Therefore, one aim of this thesis is to 
crystallize full-length eIF4F complex, and further figure out why eIF4E, eIF4G, 
eIF4A and eIF4B work cooperatively on mRNA activation and the reason for the 
regulation of their activity. As identification of crystallization condition would fail, 
other structural probing methods (for example, cross-linking) should be performed. 
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2 
Materials and methods 
2.1 Cloning 
2.1.1 Materials  
2.1.1.1 Chemicals 
All standard chemicals, which are not listed following, were purchased from 
AppliChen, Bio-Rad, Biotech, Fluka, Merck, Roth or Sigma-Aldrich. The purity 
grade pro analysis was chosen. 
2.1.1.2 Buffers 
TAE (1 ×) buffer was used for making the agarose gels and as the running buffer of 
agarose gel electrophoresis.  
Table 2.1: Standard buffers for cloning 
Buffer Composition 
TAE (50 ×) 2 M Tris acetate, pH 8.0, 50 mM EDTA  
DNA loading buffer (6 ×) 0.25% Bromophenole blue, 0.25% xylene cyanol FF, 30% Glycerol 
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2.1.1.3 Cell media 
LB, 2 × YT and SOC media were used for growing cells intended for cloning. To 
make agar plates, 1.5% (w/v) (final concentration) agar was supplemented prior to 
autoclaving.  
Table 2.2: Media for bacterial cells 
Medium Composition 
LB 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 0.5% (w/v) NaCl 
2 × YT 1.6% (w/v) Tryptone, 1% (w/v) Yeast extract, 1% (w/v) NaCl 
SOC medium 2% (w/v) Tryptone, 0.55% (w/v) yeast extract, 10 mM NaCl, 10 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose 
2.1.1.4 E. coli  host strains 
Escherichia coli (E. coli) strain XL1-Blue was used for routine cloning, while 
DH10BacTM was utilized for generation of the recombinant bacmid that contains the 
gene of interest (i.e. full-length eIF4G, see 2.2.2.2). 
Table 2.3: Cells used for cloning 
Cells Key features Reference 
XL1-Blue  Endonuclease and recombination deficient; an excellent host 
strain for routine cloning 
Agilent 
DH10BacTM Contains baculovirus shuttle vector (bacmid) and a 
transposition help plasmid; allows generation of a 
recombinant bacmid 
Invitrogen 
2.1.1.5 Enzymes and reagents 
Appropriate buffers provided by the suppliers were used for the enzymes. All 
antibiotics were prepared in a 1000 × stock solutions. Antibiotics were purchased 
from Roth.  
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Table 2.4: Enzymes and reagents used for cloning 
Enzyme and standard protein Supplier 
dNTPs (10mM each) Fermentas 
Pfu DNA polymerase Fermentas 
Phusion DNA polymerase Finnzymes 
Taq DNA polymerase Promega 
GelRed VWR 







T4 DNA ligase Fermentas 
 
Table 2.5: Antibiotics 
Antibiotics Final concentration used 
Ampicillin 100 µg/ml 
Chloramphenicol 34 µg/ml 
Gentamicin 7 µg/ml 
Kanamycin 50 µg/ml 
Tetracycline 15 µg/ml 
2.1.1.6 Genomic DNA 
Saccharomyces cerevisiae S288c genomic DNA was a collection of our group 
(Department for Molecular Structure Biology, MSB). The organism Chaetomium 
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thermophilum DSM 1495 was a kind gift of Prof. Dr. Ed Hurt (Heidelberg 
University). The genomic DNA of Chaetomium thermophilum was extracted by 
Bernhard Kuhle. 
2.1.1.7 Instruments 
Machines used in the procedure of cloning are listed in Table 2.7. 
Table 2.6: Machines used in the procedure of cloning 
Machine Supplier 
Adjustable pipettes Eppendorf 
Agarose gel electrophoresis chamber Bio-Rad 
BioPhotometer Eppendorf 
Balance Sartorius 
GelDoc EQ System Bio-Rad 
HLC block thermostat BT 1302 Techne 
Incubator Mytron Schütt 
Innova 4230 incubator New Brunswick 
Magnetic stirrer IKAMAG REO IKA 
MiniSpin plus Eppendorf 
PCR mastercycler gradient Eppendorf 
PCR-Whatman Biometra T personal Biometra 
pH-Meter Beckman Beckman Coulter 
Pipette Controller Accu-Jet pro Brand 
Table centrifuge 5415R Eppendorf 
Thermomixer comfort Eppendorf 
Unitron incubator shaker Infors 
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2.1.1.8 Molecular biology kits 
Kits were used following the user manuals provided by the suppliers. 
Table 2.7: Commercial molecular biology kits 
Kit Supplier 
peqGOLD Gel Extraction Kit PEQLAB 
peqGOLD MicroSpin Cycle-Pure Kit PEQLAB 
peqGOLD Plasmid Miniprep Kit PEQLAB 
QIAquick Gel Extraction Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
In-fusion® HD Cloning Kit Clontech 
BigDye® Terminator v1.1 Cycle Sequencing Kit Life technologies 
2.1.2 Methods 
2.1.2.1 Determination of nucleic acid concentration  
The concentration of nucleic acids in solution was determined by measuring the 
absorption at the wavelength of 260 nm, using a spectrophotometer. The 
concentration of DNA or RNA was then calculated as follows [132]: 
• dsDNA Concentration (µg/ml) = (OD260) × (dilution factor) × 50 
• ssDNA Concentration (µg/ml) = (OD260) × (dilution factor) × 33 
• ssRNA Concentration (µg/ml)= (OD260) × (dilution factor) × 40 
2.1.2.2 Polymerase chain reaction (PCR)  
Genes or gene fragments were amplified by applying the polymerase chain reactions 
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(PCR) [133]. The compositions of a typical PCR and the procedure of PCR cycles are 
given below. 
Table 2.8: Recipe of a standard PCR 
Item Volume (µl) 
5×  (or 10×) buffer 10 (or 5) 
dNTPs (10 mM each) 1 
Forward Primer (10 pmol) 2.5 
Reverse Primer (10 pmol) 2.5 
Template (100 ng/µl) 0.5 
Polymerase (10 U/µl) 1 
H2O 32.5 (or 37.5) 
Total volume 50 
Table 2.9: Procedure of PCR cycles 
Cycles Temperature (℃) Time 
1 ×   95 (initial denaturation) 3 min 
20-30 ×  95 (denaturation) 30 sec 
 55-61 (annealing) 30 sec 
 72 (elongation) 30 sec - 6 min 
1 ×  72 (final elongation) 10 min 
    PCR products were purified either using a PCR purification kit (if the samples 
were pure enough), or a gel extraction kit. In the later case, an agarose gel 
electrophoresis (see 2.1.2.3) was first performed, and the bands containing the 
DNA of interest were excised from the gel. 
2.1.2.3 Agarose gel electrophoresis  
To separate DNA fragments from PCR or a restriction digest reaction, agarose gel 
electrophoresis was used for both analytical visualization and purification. Gels 
were prepared with 1 × TAE buffer, 0.5 × GelRed and agarose in different 
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concentrations, ranging from 0.8% to 2% according to the size of the nucleic acid 
fragments. Gels were run at a constant current of 400 mA in 1 × TAE buffer. DNA 
bands were visualized by using GelDoc EQ System at UV 254 nm. 
In necessary cases, DNA bands of interest were excised from the gels with a 
sterile blade. DNA fragments were extracted from the gel by using gel extraction kit 
following the user manuals. 
2.1.2.4 Preparation of chemically competent E. coli  cells 
Chemically competent E. coli cells were generated using the CaCl2 method [134]. 
2.5 ml of cells cultured overnight were inoculated into 500 ml 2 × YT medium 
supplemented with appropriate antibiotics. Cells were grown at 37 ℃ with shaking 
at 220 rpm until an OD600 of 0.5-0.6 was reached and then incubated on ice for 
30 min. Cells were collected in sterile bottles by centrifugation (3000 × g, 10 min, 
4 ℃). The cell pellet was resuspended in 125 ml pre-cooled 0.1 M MgCl2, placed on 
ice for 20 min and harvested by centrifugation (2500 × g, 12 min, 4 ℃). Cells were 
additional washed with 250 ml 0.1 M CaCl2 (20 min incubation on ice and then 
centrifugation) and finally resuspended in 5 ml pre-cooled solution containing 0.1 M 
CaCl2 and 15 % glycerol. The competent cells were aliquoted in cold Eppendorf tubes, 
flash-frozen in liquid nitrogen and stored at -80 ℃. 
2.1.2.5 Molecular cloning  
Digestion-ligation based cloning   Target DNA fragments produced by PCR 
and selected vectors were digested with identical restriction enzymes, resulting in 
compatible ends in vectors and DNA fragments. Buffers, temperatures as well as 
the amount of vector, DNA and enzymes for the digestion reactions were chosen 
according to the instruction of suppliers. In the case of vector digestion, Calf 
intestinal alkaline phosphatase (CIAP, 0.01 unit per pmol DNA) was added 30 min 
before stopping the reaction. The digested products were purified using either PCR 
purification kits or gel extraction kits.  
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Digested plasmid DNA (usually 100 ng) and insert DNA (3-5 fold molar excess) 
were ligated by T4 DNA ligase (500 units). Typically, ligation reactions were 
incubated at room temperature for 1-1.5 hours. The ligation reaction mixture was 
transformed into XL1-Blue E. coli cells. 
    In-fusion cloning   In-fusion HD Cloning kit (Clontech) allows fast, 
directional cloning of several DNA fragments into one vector at the same time at 
any location. Therefore, it has great advantage when the genomic DNA, of which the 
complete genes are usually separated by several introns, is used as the PCR 
template. In this study, this cloning method was extensively used (see Table 2.12). 
Primers with 15 nucleotides overlap to the adjacent DNA fragment were designed 
according to the detailed description of the In-fusion user manual. 100 ng plasmid 
DNA and 3-fold molar excess of insert DNA fragments were mixed and incubated at 
50 ℃ for 15 min. Reaction mixture was then transformed into E. coli XL1-Blue cells. 
2.1.2.6 Site-directed mutagenesis  
Desired point mutations were introduced according to the instruction of 
QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies). Different 
from normal PCR (see 2.1.2.2), 1.5 µl DMSO was additionally supplied. The 
resulting clones were verified by DNA sequencing (see 2.1.2.8). 
2.1.2.7 Transformation  
Approximately 100 ng plasmid DNA, or reaction mixtures from ligation or In-fusion 
were individually added into ~100 µl just thawed chemically competent cells. After 
30 min incubation on ice, cells were heat-shocked at 42 ℃ for 90 sec and placed on 
ice for 3 min. Then 1 ml 2 × YT medium (without antibiotics) was supplied and the 
cell suspension was incubated at 37 ℃ with shaking for 45 min to recovery. Finally, 
the cell suspension was distributed onto a 2 × YT agar plate that contains the 
appropriate antibiotic(s). Transformation of pFastBac HT B into DH10BacTM cells is 
described in Section 2.2.2.4. 
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2.1.2.8 DNA sequencing  
The sequencing of DNA was performed to assure the correct sequences of the 
desirable inserts. Compositions of the sequencing PCR and procedure of the PCR 
cycles are given in Table 2.10 and Table 2.11, respectively.  
Table 2.10: Recipe of sequencing PCR. The sequencing primers are used according to  
 the requirement of the vectors. 
Item Volume (µl) 
Plasmid  1 
Sequencing primer (10 pmol) 1 
BigDye Terminator v1.1 1.5 
Sequencing buffer 1.5 
H2O 5 
Total volume 10 
Table 2.11: Procedure of sequencing PCR cycles 
Cycle Temperature (℃) Time 
1 ×   95 (initial denaturation) 2 min 
25 ×  95 (denaturation) 20 sec 
 55 (annealing) 20 sec 
 60 (elongation) 4 min 
    DNA was precipitated by addition of 1 µl 3 M NaOAc, 1 µl 125 mM EDTA and 
50 µl ethanol. The mixture was incubated for 5 min and then centrifuged at 20,000 × 
g for 20 min. The DNA pellet was washed with 70 µl of 70 % (v/v) ethanol and dried 
at room temperature. The pellet was finally resuspended in formamide and sent to 
Department of Developmental Biochemistry, University of Göttingen, for 
sequencing. 
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2.1.3 Plasmids 
Genes were individually cloned into vector pGEX6P-1 (GE Healthcare), modified 
pET15b (MSB), modified pET22b (MSB) and modified pETDuet (MSB) for 
expression in E. coli cell. Yeast eIF4G was also cloned into pFastBac HT B 
(Invitrogen) for expression in insect cells. DNA sequencing verified that the 
sequences of inserts are correct. In order to amplify plasmid DNAs, the plasmids 
were respectively transformed into XL1-Blue E. coli cells and cultured at 37 ℃ 
overnight. Plasmids isolation was carried out using Miniprep kits. Table 2.12 lists 
all plasmids generated in this study. 
Table 2.12: Expression vectors designed and generated in this study. ct: Chaetomium 
thermophilum; sc: Saccharomyces cerevisiae; DL: digestion-ligation based cloning; IF: 
In-fusion cloning; PP: PreScission protease; TEV: Tobacco Etch Virus protease; Thrb: 
Thrombin protease. 
Plasmid Tag(s) Resistance Cloning procedure  Protease 
pGEX6P-1_ct rpS9e FL (1-190) N-GST  Ampicillin IF PP 
pGEX6P-1_ct rpS9e (1-183) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3a FL (1-1086) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3a (1-906) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b FL (1-746) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b (24-135) N-GST  Ampicillin IF PP 
mpETDuet_ct eIF3b (41-746) N-His6 Ampicillin DL (BamHI, Hind3) TEV 
mpETDuet_ct eIF3b (167-746) N-His6 Ampicillin DL (BamHI, Hind3) TEV 
pGEX6P-1_ct eIF3b (167-625) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b (167-640) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b (167-670) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b (167-704) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3b (167-720) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3g FL (1-289) N-GST  Ampicillin IF PP 
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Plasmid Tag(s) Resistance Cloning procedure  Protease 
pGEX6P-1_ct eIF3g (26-286) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3g (26-286) (∆ 151-179) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3g (26-150) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3g (180-286) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3i (1-330) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3j FL (1-279) N-GST  Ampicillin IF PP 
pGEX6P-1_ct eIF3j (53-238) N-GST  Ampicillin IF PP 
pGEX6P-1_sc eIF3j FL (1-265) N-GST  Ampicillin DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF3j (20-218) N-GST  Ampicillin DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF3j (56-218) N-GST  Ampicillin DL (BamHI, XhoI) PP 
mpET15b_sc eIF4A FL (1-395) N-His6  Ampicillin DL (NdeI, XhoI) TEV 
pGEX6P-1_sc eIF4A (14-395) N-GST  Ampicillin IF PP 
pGEX6P-1_sc eIF4A (14-395) 23K→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 25D→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 43E→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 67Q→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 125I→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 205P→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 284K→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 296Q→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 297Q→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 322R→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 340N→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4A (14-395) 342E→Bpa N-GST  Ampicillin QuikChange PP 
pGEX6P-1_sc eIF4B FL(1-436) N-GST  Ampicillin DL (BamHI, NotI) PP 
mpET15b_sc eIF4E FL(1-213) N-His6  Ampicillin DL (NdeI, XhoI) TEV 
pGEX6P-1_sc eIF4E FL(1-213) N-GST  Ampicillin DL (NdeI, XhoI) PP 
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Plasmid Tag(s) Resistance Cloning procedure  Protease 
pGEX6P-1_sc eIF4E (28-213) N-GST Ampicillin DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4E (36-213) N-GST Ampicillin DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G FL (1-952) N-GST Ampicillin DL (BamHI, XhoI) PP 
mpET22b_sc eIF4G FL (1-952) N-Strep, 
C-His6 
Ampicillin DL (BamHI, XhoI) Thrb(N) 
pFastBac HTB_sc eIF4G FL N-His6 Ampicillin 
Gentamycin 
DL (BamHI, XhoI) TEV 
pGEX6P-1_sc eIF4G (1-617) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (410-853) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (410-883) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (410-952) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (468-617) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (468-853) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (468-883) N-GST Ampicillin  DL (BamHI, XhoI) PP 
pGEX6P-1_sc eIF4G (468-952) N-GST Ampicillin  DL (BamHI, XhoI) PP 
mpET Duet_sc eIF4G (542-883) N-His6 Ampicillin  DL (BamHI, HindIII) TEV 
mpET Duet_sc eIF4G (542-952) N-His6 Ampicillin  DL (BamHI, HindIII) TEV 
mpET Duet_sc eIF4G (572-853) N-His6 Ampicillin  DL (BamHI, HindIII) TEV 
mpET Duet_sc eIF4G (572-952) N-His6 Ampicillin  DL (BamHI, HindIII) TEV 
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2.2 Protein expression and purification 
Materials and methods that are provided in the Section 2.1 will not be redundantly 
listed here and later. 
2.2.1 Materials 
2.2.1.1 Instruments 
Table 2.13: Machines used in protein expression and purification 
Machine Supplier 
Centrifuge Allegra 21R Beckman Coulter 
Centrifuge Avanti J-20 XPI Beckman Coulter 
Centrifuge Avanti J-30 I Beckman Coulter 
Rotor JA-20 Beckman Coulter 
Rotor JA-30.5 Beckman Coulter 
Rotor JA-8.1000 Beckman Coulter 
Rotor S4180 Beckman Coulter 
Axiovert 25 inverse microscope Carl Zeiss 
Branson sonifier 250 Fisher Scientific 
Micro fluidizer M110S Microfluidics 
Platform shaker Promax 1020 Heidolph 
Prettl Telstar Typ Bio II A TelStar 
SDS-PAGE system Hoefer miniVE Amersham Pharma 
Table mixer RM5 Schütt 
Unitron incubator shakers Infors 
Ultra Centrifugal Mill ZM Retsch 
UV lamp (365 nm) Vilber Lourmat 
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2.2.1.2 Chromatography systems and columns 
Äkta Prime and Äkta Purifier (GE Healthcare) were used for purifying proteins. 
Samples were loaded on the columns by using loops with volume of 0.5 ml, 1 ml, 5 
ml, 10 ml, 50 ml and 150 ml, respectively. Columns used in this study are listed 
below (Table 2.14). 
Table 2.14: Chromatographic resins and columns 
Name Supplier 
GSH Sepharose/GSTrap 5ml GE Healthcare 
Ni-NTA Sepharose/HisTrap 5ml GE Healthcare 
HiPrep Desalting 26/10 GE Healthcare 
Source 30Q GE Healthcare 
SP Sepharose GE Healthcare 
StrepTactin HP Sepharose 5ml GE Healthcare 
Superdex 75 (26/60) GE Healthcare 
Superdex 200 (26/60) GE Healthcare 
Superdex 200 (16/60) GE Healthcare 
Superdex 200 (10/300) GE Healthcare 
2.2.1.3 Buffers 
Table 2.15: Standard buffer routinely used in the work regarding proteins  
Buffer Composition 
SDS loading buffer (2 ×) 100 mM Tris pH 6.8, 4% (w/v) SDS, 4% (v/v) β-ME, 20% (v/v) 
Glycerol, 0.02% (w/v) Bromophenol blue 
SDS loading buffer (5 ×) 250 mM Tris pH 6.8, 10% (w/v) SDS, 10% (v/v) β-ME, 50% (v/v) 
Glycerol, 0.05% (w/v) Bromophenol blue 
SDS running buffer (10 ×) 250 mM Tris pH 6.8, 2 mM Glycine, 1% (w/v) SDS 
Coomassie staining solution 0.025% (w/v) Coomassie (R250); 0.025% (w/v) Coomassie 
(G250); 30% (v/v) isopropanol; 7.5% (v/v) acetic acid 
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Buffer Composition 
Destaining solution  40% (v/v) ethanol, 20% (v/v) acetic acid 
Blot transfer buffer (1 ×) 25 mM Tris, 192 mM Glycin, 20 % (v/v) methanol 
TBST 150 mM NaCl, 20 mM Tris/HCl, pH 8.0, 0.2 % Tween 20 
Blot Buffer A 100 mM Tris/HCl, pH 9.5, 100 mM NaCl, 5 mM MgCl2 
2.2.1.4 Enzymes and reagents 
The stock concentration of DNAase and ALP (a mixture of Aprotinin, Leupeptin and 
Pepstatin) is 2 mg/ml and 100 mg/ml, respectively. 
Table 2.16: Enzymes and special reagents for protein expression and purification 
Name Supplier 
β-Mercaptoehanol (β-ME) Roth 
Bradford Roth 
DNAase Applichen 
Dithiothreitol (DTT) Applichen 
IPTGa Roth 
PMSFb Applichen 
Proteinase inhibitor mixture ALP MSB 
Proteinase inhibitor tablets (Complete) Roche 
PreScission protease (PP) MSB 
TEV protease MSB 
  a Isopropyl β-D-1-thiogalactopyranoside; b PMSF: Phenylmethylsulfonyl fluoride.  
2.2.1.5 Protein expression cells 
Escherichia coli (E. coli) strains BL21 (DE3) and Rosetta 2 (DE3) were used to 
express proteins. B834 (DE3) was used to produce selenomethionine derivative 
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cteIF3b. Sf9 insect cells were used to propagate recombinant baculoviral stocks and 
preliminary expression experiments. High FiveTM cells were used for high-level 
expression of His tagged full-length yeast eIF4G protein. 
Table 2.17: Cells used for expressing recombinant proteins 
Cells Key features Reference 
BL21 (DE3) T7 RNA polymerase controlled by Lac regulatory construct; 
IPTG inducible  
Novagen 
Rosetta 2 (DE3) Enhance the expression of eukaryotic proteins; pRARE2 
(Cam); IPTG inducible 
Novagen 
B834 (DE3) Methionine auxotroph; seleno-Met labeling; IPTG inducible Novagen 
Sf9 Isolate and propagate recombinant baculoviral stocks; 
produce recombinant protein 
Invitrogen 
High FiveTM High-level expression of recombinant protein using 
Baculovirus Expression Vector system (BEVS) 
Invitrogen 
2.2.1.6 Cell media for protein expression 
Insect cell media SF900 III SFM and Express Five® SFM were bought from 
Invitrogen. LB and 2 × YT are provided in 2.1.1.3 
Table 2.18: Media for bacterial cells used for protein expression 
Medium Composition 
ZY 10 g N-Z-amine AS, 5 g yeast extract, 950 ml of deionized water 
ZYM-5052 950 ml ZY media supplemented with 2 ml MgSO4 (1 M), 200µl trace 
elements (1000× solution), 20 ml of 50× 5052, 20 ml of 50× M 
50 × 5052 25% glycerol, 2.5% glucose, 10% α-lactose 
50 × M 1.25 M Na2HPO4, 1.25 M KH2PO4, 2.5 M NH4Cl, 0.25 M Na2SO4 
1000 × Trace elements 50 mM FeCl3, 20 mM CaCl2, 10 mM MnCl2, 10 mM ZnSO4, 2 mM 
CoCl2, 2 mM CuCl2, 2 mM NiCl2, 2 mM Na2MoO4, 2 mM Na2SeO3, 
2 mM H3BO3 in ~60 mM HCl 
M9 minimal medium 1L medium contains: 20 ml of 50× M, 20% glucose, 1 mM MgSO4, 0.3 
mM CaCl2, 1 µg biotin, 1 µg thiamin, 1 ml trace elements (1000×) 
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2.2.2 Methods 
2.2.2.1 Protein expression using bacterial cells 
    IPTG induction   Recombinant proteins were individually expressed in 
E. coli strain BL21 (DE3) (all proteins, except eIF4B and eIF4G) or Rosetta 2 (DE3) 
(all proteins) grown in 2 ×  YT medium supplemented with appropriate antibiotic(s).  
Expression of target proteins was induced by addition of 0.25 mM isopropyl 
β-D-thiogalactopyranoside (IPTG) when an OD600 of ~1.0 was reached. After 
induction, cells were cultured at 16 ℃ for 4-6 hours (for eIF4A and rpS9e) or overnight. 
The speed of the shaking was set up to 220 rpm. 
Auto-induction   In order to obtain the full-length yeast eIF4G protein in a 
reasonable amount, auto-induction was also tried [135]. Cells were grown in 
ZYM-5052 auto-inducing complex medium containing 100 mg/L ampicillin and 
34 mg/L chloramphenicol at 16 ℃ for two days. 
Expression of unnatural amino acid Bpa labeled proteins 
Plasmids that harbor sceIF4A mutants were individually transformed into a special 
BL21 (DE3) E. coli strain (kind gift of Heinz Neumann, Göttingen), which hold a 
pSup-Bpa plasmid (resistant to chloramphenicol). pSup-Bpa encodes a suppressor 
tRNA and an engineered aminoacyl-tRNA synthetase that charges the suppressor 
tRNA with the unnatural amino acid Bpa (p-benzoyl-L-phenylalanine). The 
suppressor tRNA is designed to base pair with the amber stop codon (UAG) that 
would be genetically mutated from a residue of interest. Therefore, the unnatural 
amino acid Bpa is able to be site-specifically inserted into a target protein [136]. 
Cells were grown in LB medium with addition of 50 mg/L ampicillin and 17 mg/L 
chloramphenicol, as well as 1 mM Bpa (kind gift of Heinz Neumann, Göttingen) at 
37 ℃. When an OD600 of ~0.6 was reached, cells were transferred to 20 ℃. In order to 
induce the expression of target protein, 0.5 mM IPTG (final concentraion) was 
added at an OD600 of ~1.0. Cells were further incubated at 20 ℃ for ~5 hours. 
Expression of SeMet substituted protein   The selenomethionine (SeMet) 
derivative cteIF3b was overexpressed in E. coli strain B834 (DE3), which is 
methionine auxotrophic. The cells were initially grown in M9 minimal medium with 
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the supply of 50 mg/L methionine. When an OD600 of ~0.6 was reached, this 
methionine-containing medium was then removed by centrifugation (2,500 × g, 
15 min, 4℃) and the cells were resuspended in new M9 medium. After the depletion 
of the residual methionine, 50 mg/L selenomethionine was supplied. Target protein 
expression was induced by addition of 0.25 mM IPTG. Cells were incubated with 
shaking at 220 rpm at 16 ℃ overnight. 
2.2.2.2 Protein expression using insect cell system 
Expression of a gene of interest using the Bac-to-Bac Baculovirus Expression 
System (Invitrogen) is far more complicated than expression in E. coli cells. It can 
be divided into following steps: (i) clone gene of interest into a chosen pFastBacTM 
donor plasmid; (ii) transformation of the pFastBacTM recombinant into DH10BacTM 
E. coli host cells for generation of a recombinant bacmid; (iii) transfection of the 
isolated recombinant bacmid DNA into a insect cell line to propagate a recombinant 
baculovirus; (iv) Amplification and titration of the recombinant baculoviral stock, 
and infection of insect cells to produce the target protein.  
Cultivation of insect cells   All operation concerning insect cells was 
carried out under sterile conditions, using a laminar flow hood. Sf9 cells were 
cultured in SF900 III SFM medium, while High FiveTM cells were grown in Express 
Five® SFM medium supplemented with 1× L-glutamine. Both cells were incubated 
at 27 ℃ in the dark. The suspension cultures were maintained in an appropriate flask, 
of which the capacity is usually four times bigger than the volume of the cells. The 
cells are shaking at 100 rpm and subcultured every day to a density of 
0.5 × 106 cells/ml. Adherent monolayer cultures were cultured in plates with 70% to 
90% occupancy. Cell viability was assessed every day under an inverse microscope. 
Preparation of recombinant bacmid   The gene of yeast eIF4G was cloned 
into pFastBacTM HT B vector and transformed into DH10BacTM E. coli cells. 
Following heat-shocking, cells were incubated at 37 ℃ for 3h in SOC medium for 
recovery and plated on LB-agar media that contain 100 µg/ml ampicillin, 50 µg/ml 
kanamycin, 10 µg/ml tetracycline, 7 µg/ml gentamicin, as well as 100 µg/ml 
Bluo-Gal and 1 mM IPTG. Cells were cultured for 2 days. White positive colonies 
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were picked and restreaked on a new LB-agar plate supplemented with all the 
antibiotics mentioned above, IPTG as well as Bluo-Gal. The blue-white screening 
was performed twice, and subsequently single white colonies were inoculated into 
5 ml LB medium for amplifying the recombinant bacmid. Recombinant bacmid 
DNAs verified by PCR were isolated using a miniprep kit，omitting the column 
purification step. Instead of column purification, the large bacmid DNAs were 
precipitated by addition of 0.6 volume of isopropanol and pelleted by centrifugation 
(15,000 × g for 30 min). Pellets were washed with 50 µl of 70% ethanol. 
Transfection of Sf9 cells   The dried recombinant bacmid pellets were 
dissolved in 20 µl autoclaved ddH2O and mixed with 200 µl of SF900 III medium. 
The transfection reagent, FuGENE 6, was also diluted in SF900 III medium (10 µl 
FuGENE 6 in 100 µl medium) and added into the bacmid containing tube. The 
mixture was incubated for 45 min and equally distributed into two wells of a 6-well 
plate (each 165 µl). Each well contains 3 ml Sf9 cells at a density of 0.3 × 106 cells/ml. 
The plates were incubated at 27 ℃ protected against light for 60 hours, and then 
the supernatant containing the V0 virus was collected. 
Virus amplification   The V0 virus was used to infect a suspension culture of 
Sf9 cells (3 ml virus to 25 ml cells). Infected Sf9 cells were counted and diluted to 
0.6 × 106 cells/ml every 24 h until cell proliferation was stopped. After proliferation 
arrest, 106 infected cells were sampled every 12 h for preliminary protein expression 
test. When the density of the cells reached 0.2-0.3 × 106 cells/ml, the V1 virus 
present in the supernatant was harvested by centrifugation (2,000 × rpm, 20 min) 
and stored at 4 ℃. Protein expression was analyzed by SDS-PAG. V2, V3 or V4 virus 
was produced by infecting Sf9 cells with previous generation of virus. Normally, the 
ratio of virus to cells was 1 to 1000 during the amplification of virus. 
Protein expression in insect cell   To determine the appropriate 
concentration of virus to be used for large scale protein expression and the time 
scale of infection, 4 flasks that each contains 25 ml High FiveTM cells at density of 
0.6-0.7 × 106 cells/ml were infected with varying volumes of virus (1:100, 1:200, 
1:500, 1:1000). After 24 h infection, cells were checked, counted and sampled every 
4 h. The amount of virus and the expression period that yielded high protein 
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production were chosen for large-scale expression. 
To express the target protein (i.e. eIF4G) in large scale, each 500 ml suspension 
High FiveTM cells cultured in a 2 L shaker flask at 0.6-0.7 × 106 cells/ml were 
infected with 1 to 2 ml virus. The cells were harvest after 36 h infection, normally 
with cell viability of 90%. 
2.2.2.3 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
analyze proteins. Depending on the size of the proteins to be separated, 8-12.5% (v/v) 
acrylamide containing gel were prepared. The recipe for the gel solutions is shown 
in Table 2.19.  
Table 2.19: Composition of separating gel (40 ml for 4 gels) 
Item 8 % 10 % 12.5 % 15 % 
1.5 M Tris Base/HCI 8.8 10 ml 10 ml 10 ml 10 ml 
H2O 18.6 ml 15.9 ml 12.6 ml 9.3 ml 
Rotiphorese Gel 30 (37.5:1) 10.7 ml 13.3 ml 16.7 ml 20 ml 
10 % SDS 400 µl 400 µl 400 µl 400 µl 
10 % APS 300 µl 300 µl 300 µl 250 µl 
TEMED 40 µl 40 µl 40 µl 30 µl 
Table 2.20: Composition of stacking gel (6%, 20 ml for 4 gels) 
Item 6 % 
0.625 M Tris Base/HCl 6.8 4 ml 
H2O 11.6 ml 
Rotiphorese Gel 30 (37.5:1) 4 ml 
10 % SDS 200 µl 
10 % APS 200 µl 
TEMED 10 µl 
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    Samples were mixed with laemmli loading buffer and heated for 2 min at 95 ℃ 
prior to loading onto the gels. Gels were run vertically in SDS-PAGE running buffer 
for ~1 h at a constant current of 40 mA. To visualize protein bands, SDS-PAGE gels 
were first stained with staining buffer and subsequently destained. The recipes of 
the buffers are provided in 2.2.1.3. Gels were scanned and documented. 
2.2.2.4 Protein concentration determination 
Protein concentrations were determined by performing the Bradford assay [137]. 
This assay is based on the absorbance shift of the dye coomassie Brilliant Blue 
G-250 (from 465 nm to 595 nm) if it binds to protein. 20 µl of protein solution was 
mixed with 980 µl of Bradford reagent (1:5 diluted with H2O). Before measuring the 
OD595 of the sample using a previously calibrated photometer, the mixture was 
incubated at room temperature for 1 min. The concentration of the protein in mg/ml 
ranging from 0.1 to 0.9 was directly read from the monitor of the photometer.  
2.2.2.5 Western blot 
Proteins were separated by SDS-PAGE and wet-blotted onto a nitrocellulose 
membrane at 90 V for 2 h at 4 ℃, using a blotting chamber (BioRad). The gel, 
membrane and filter papers were pre-wetted in cold transfer buffer prior to transfer. 
The materials were stacked in the following order: 
• Case (black side) (-) 
• Sponge 
• Whatman paper 
• Gel 
• Membrane 
• Whatman paper 
• Sponge 
• Case (white side) (+) 
    Air bubbles trapped between the layers of the assembly were carefully removed. 
In order to decrease the non-specific binding of antibodies, the membrane was first 
blocked in blocking buffer for 2 h with shaking. After three 10-minute washes, the 
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membrane was incubated with the primary antibody (mouse anti-His) 1:1000 
diluted in blotting buffer overnight, 4 ℃ or 2-4 h at room temperature. The excess of 
the first antibody was washed away with TBST (three 10-minute washing). The 
membrane was then incubated with 1:5000 diluted alkaline phosphatase (AP) 
conjugated secondary antibody (goat anti-mouse AP) for 1 h at room temperature. 
After three 5-minute washes with buffer A, proteins were detected by directly dying. 
The membrane was incubated with 66 µl NTB stock, 33 µl BCIP stock and 10 ml 
buffer A for 2-5 min and washed with H2O. 
2.2.2.6 Cell harvest and lysis 
Cells were harvested from expression cultures by centrifugation (4,800 × g, 20 min, 
4 ℃). The cell pellets were washed with 50 mM HEPES/NaOH, pH 7.5, 200 mM 
NaCl and then pelleted again for either immediate lysis or storage at -20 ℃. The 
lysis buffer usually contained 20 mM HEPES/NaOH, pH 6.8-8.0, 500 mM NaCl, 
2.5 mM β-mercaptoethanol (β-ME) and 5-10% glycerol. E. coli cells were ruptured 
using a Microfuidizer in which the cell suspension was pushed through a chamber 
at a high pressure of 0.55 MPa for five times. By contrast, insect cells were gently 
disrupted using an ultra centrifugal mill (Retsch ZM 200). The debris was separated 
via centrifugation (30,000 × g, 35 min, 4 ℃). The supernatant containing the protein 
of interest was then loaded onto a column for purification. 
2.2.2.7 Protein purification 
For GST tagged proteins the supernatant after cell rupture and centrifugation was 
loaded onto a GSTrap column (GE Healthcare) equilibrated in lysis buffer. Once 
loaded in the column, samples were extensively washed with lysis buffer 
supplemented with 1 M LiCl (especially for these RNA-binding proteins, e.g. eIF4A, 
eIF4B, eIF4G). Then the protein-bound column was equilibrated in a low salt buffer 
(25 mM HEPES/NaOH, pH 7.5, 100 (200 for eIF3g, eIF4G468-853 and eIF4G486-853) 
mM NaCl, 5% glycerol and 5 mM β-ME). The GST fusion proteins were eluted with 
the low salt buffer supplemented with 30 mM reduced glutathione. The GST-tag 
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was cleaved with PreScission protease overnight at 4 °C, with a 1:100 mass ratio of 
protease to fusion protein.  
For the His6-tagged proteins the supernatant was applied to an HisTrap 
column (GE Healthcare). After loading in the column, samples were extensively 
washed with lysis buffer containing additional 1 M LiCl. Then the protein-bound 
column was equilibrated in a low salt buffer (25 mM HEPES/NaOH, pH 7.5, 
100 (200 for eIF3a) mM NaCl, 5% glycerol and 5 mM β-ME). The His6 fusion 
proteins were eluted applying a linear gradient to the 400 mM imidazole-containing 
low salt buffer containing 400 mM imidazole. The His6-tag was cleaved with tobacco 
etch virus (TEV) protease overnight at 4 °C, with a 1:100 mass ratio of protease to 
fusion protein.  
To further purify full-length eIF3b, eIF3g, eIF4A, eIF4B, eIF4G, as well as 
eIF4G468-853 and eIF4G486-853, respectively, the protein was applied onto an ion 
exchange column (GE healthcare) (Source 30Q for eIF3b, eIF4A and eIF4B, 
SP Sepharose for eIF3g, full-length eIF4G, eIF4G468-853 and eIF4G486-853). Prior to 
sample loading, the ion exchange column was equilibrated in buffer A (25 mM 
HEPES/NaOH, pH 7.5, 100 mM NaCl (200 mM NaCl for eIF3g, eIF4G468-853 and 
eIF4G486-853), 5% glycerol and 5 mM β-ME). The target protein was eluted with a 
linear gradient of buffer B (25 mM HEPES/NaOH, pH 7.5, 1 M NaCl, 5% glycerol 
and 5 mM β-ME).  
To further purify eIF3a the protein was loaded onto a HiTrap Heparin HP 
column (GE healthcare) that was equilibrated in buffer A (20 mM HEPES/NaOH, 
pH 7.3, 200 mM NaCl, 5% glycerol and 5 mM β-ME). eIF3a was eluted with a linear 
gradient of buffer B (20 mM HEPES/NaOH, pH 7.5, 1 M NaCl, 10% glycerol and 5 
mM β-ME).  
Finally, a Superdex 75 (26/60) or a Superdex 200 (26/60) gel filtration column 
(GE Healthcare) was used to purify all the proteins, including individual full-length 
subunits, truncations, as well as subcomplexes. The gel filtration buffer contained 
10 mM HEPES/NaOH, pH 7.5, 100-150 mM NaCl, 2% glycerol and 2 mM DTT. 
Fractions that contained the target proteins were pooled, concentrated, flash-frozen 
in liquid nitrogen and stored at -80 °C.  
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2.3 Protein characterization 
2.3.1 Thermal shift assay 
Thermal shift assay, also called differential scanning fluorimetry (DSF), was used to 
choose conditions in which the target protein is stable over long periods of time. 
~5 µM purified protein supplemented with 1 × SYPRO orange fluorescent dye was 
pipetted into a 96-well plate (20 µl in each well). The temperature controlled by a 
thermocycler was increased from 25 °C to 95 °C, and the fluorescence emission was 
read in steps of 1 °C/min with 30 sec hold between reads. The fluorescence intensity 
was plotted as a function of temperature. Different buffers (varying the chemical 
composition and pH) and salt concentration were tested for their ability to stabilize 
the target protein. The curve obtained directly from each condition of the 
experiment was normalized and adjusted against the background signal of the 
fluorophore in the buffer. The melting temperatures (Tm) reflected by the inflection 
points of the curves were compared, and the reasonable condition with the highest 
Tm was chosen. 
2.3.2 Multi-angle light scattering combined with size 
exclusion chromatography 
Multi-angle light scattering (MALS) combined with size exclusion chromatography 
was applied to determine the absolute molar mass of the protein of interest. ~50 µg 
protein sample in a volume of 400 µl was injected onto an analytical 
Superdex 200 (10/300) column (GE healthcare), which was equilibrated with 
25 mM HEPES/NaOH, pH 7.5, 100 mM NaCl. The elution from the column was 
monitored by a multi-angle light scattering detector, Wyatt miniDAWN TREOS. 
The data were analyzed using supplied ASTRA6 software. 
Materials and methods 
	   49 
2.3.3 Limited proteolysis 
The flexible regions of the target proteins (e.g. exposed loops, disordered termini, or 
dynamic domain linkers) usually impair the formation of crystals. Removing such 
flexible parts from a protein using limited proteolysis results in more compact and 
conformationally homogeneous molecules or compact single domains. Hence, the 
crystallization becomes possible and easier, as well as the crystals diffract better.  
Different proteases (e.g. chymotrypsin, trypsin, thermolysin, Proteinase K, 
gluC) were tested for each protein or complex of interest. Enzyme/substrate ratio 
(1:500, 1:1000, 1:2500, 1:5000), temperature (4 °C and 20°C) and time of digestion (5 
min, 20 min, 1h, 2h, 4h, 6h, 1d, 2d, 4d) were varied to find the best-digested product. 
~7 µg protein was used for each reaction in gel filtration buffer. The reactions were 
stopped by addition of SDS-PAGE loading buffer. The digested samples were 
evaluated by SDS-PAGE. 
2.3.4 Electrophoretic mobility shift assay (EMSA) 
In each reaction, 1 µg RNA oligonucleotides were mixed with 5-fold molar excess of 
protein(s). Before loading onto a 2 % agarose gel, the mixture was incubated at 4 ℃ 
for 1 h. Agarose gel electrophoresis was performed as described in 2.1.2.3. 
2.3.5 GST pull-down 
GST pull-down assays were performed as described in Liu Y et al., 2014 [138]. 50 µg 
GST fusion protein was mixed with 2-fold molar excess of non-tagged protein in a 
buffer containing 25 mM HEPES/NaOH, pH 7.5, 100 mM NaCl, 5% glycerol and 2.5 
mM β-ME and incubated with 100 µl glutathione beads for 30 min. After washing 
four times with 1 mL buffer, bound protein was eluted with the same buffer 
supplemented with 30 mM reduced glutathione. 
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2.3.6 Cobalt pull-down 
50 µg of His-tagged protein was mixed with 2-fold molar excess of non-tagged 
protein(s) in a buffer that contained 25 mM HEPES/NaOH, pH 7.5, 100 mM NaCl, 
5% glycerol and 2.5 mM β-ME. The mixture was incubated with 100 µl of cobalt 
charged TALON (Clontech) beads for 30 min. After washing with 1 mL buffer for 
four times, bound protein was eluted with the same buffer supplemented with 
500 mM imidazole. 
2.3.7 Analytical gel filtration analysis 
An analytical Superdex 200 (10/300) column (GE healthcare) was used for in vitro 
protein interaction test. In each case, ~50 µg protein in a volume of 400 µl was 
injected on the column equilibrated to the buffer that contained 25 mM 
HEPES/NaOH, pH 7.5, 100-150 mM NaCl, 5% glycerol and 2.5 mM β-ME.  
2.3.8 Co-sedimentation 
Interaction between 40S ribosomal subunit and full-length eIF3b or its truncations 
was tested by sedimentation experiment (in collaboration with S. Schell and 
A. Chari). Purified 40S was incubated with 4, 8, 12, 16, 20, or 5, 15-fold molar excess 
of eIF3b proteins for 30 minutes at room temperature. Mixtures were then loaded 
on a 7.5% sucrose cushion and centrifuged through a 30% sucrose cushion with a 
100,000 rpm speed for 2 hr at 4 °C using a MLA-130 rotor (Beckman). Supernatants 
were carefully removed, and the pellets were resuspended. Both sucrose cushions 
and resuspension buffer contained 50 mM KCl, 50 mM BisTris, pH 6.8, 10 mM 
MgCl2, and 5 mM DTT. 
2.3.9 Crosslinking 
Unnatural amino acid p-benzoyl-L-phenylalanine (Bpa) was site-specifically 
incorporated into sceIF4A (see Section 2.2.2.1). Upon UV irradiation, Bpa forms a 
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diradical and reacts with nearby C-H bonds (in 3 Å radius) [139] (Figure 2.1). 
Crosslinking was performed in a self-made 36-well metal plate on ice in buffer 
containing 20 mM HEPES/NaOH, pH 7.5, 100 mM NaCl, 2 mM MgCl2 and 1 mM 
DTT. The crosslinking reactions were induced by high intensity long-wave (365 nm) 
ultraviolet light (Vilber Lourmat) for 5 min and 30 min. ~3 µg of protein was used 
per reaction. The samples were separated by SDS-PAGE.  
 
 
Figure 2.1: Structure of Bpa and the mechanism of the UV0induced crosslinking. Upon UV exposure, 
Bpa forms a diradical and further inserted into a C-H bond within 3 Å radius. 
2.3.10 Characterization of ATPase activity 
The ATPase activity of eIF4A was determined using the EnzCheck® Phosphate 
Assay kit (Invitrogen). When inorganic phosphate (Pi) is present in solution, 
2-amino-6-mercapto-7-methypurine riboside (MESG) is converted to ribose 
1-phosphate and 2-amino-6-mercapto-7-methypurine, which is catalyzed by purine 
nucleoside phosphorylase (PNP) (Figure 2.2). The accompanying change in 
absorption from 330 nm (substrate) to 360 nm (product) enables to quantify the free 
phosphate ion consumed in the reaction. Thus the increase of absorption at 360 nm 
is directly proportional to the rate of dephosphorylation reaction that stimulated by 
an ATPase [140]. 
1 µM eIF4A was mixed with 1 µl PNP, 20 µl MESG as well as 5 µM RNA into a 
buffer that contains 20 mM HEPES/NaOH, pH 7.0, 100 mM NaCl, 2 mM MgCl2. 
The total volume of the reaction was 100 µl. Mixtures were incubated at 20 ℃ for 10 
min and measurements were started by addition of ATP to a final concentration 
ranging from 0 to 1 mM. The absorbance at 360 nm was recorded every two seconds 
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Figure 2.2: Mechanism of the EnzCheck® Phosphate Assay kit. Purine nucleoside phosphorylase (PNP) 
catalyzes 2-amino-6-mercapto-7-methypurine riboside (MESG) to 2-amino-6-mercapto-7-methypurine 
and ribose-1-phosphate. The accompanying absorption maximum change, from 330 nm to 360 nm, 
allows the quantitation of inorganic phosphate released form an ATP hydrolysis reaction. 
    The initial velocity (V0) of a reaction was determined by measuring the slope of 
the absorption at very beginning time point. In order to reach the velocity 
maximum (Vmax), the concentration of the substrate (ATP) was titrated and each 
concentration was measured independently for three times. Negative controls 
without ATP or without protein were performed to assure that the signal origin 
was due to the ATPase activity of the protein. The amount of consumed and thus 
released inorganic phosphate was calculated according to the standard absorption 
curve of phosphate. The Michaelis-Menten equation was employed to determine 
the kinetic parameters, i.e. the Michaelis constant KM and the maximal velocity 
Vmax. This calculation was carried out using SigmaPlot (Systat Software Inc.). The 
catalytic constant (kcat) equals Vmax /enzyme concentration. 





                     [S]: concentration of the substrate 
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2.3.11 Characterization of helicase activity 
The helicase activity of eIF4A was primarily tested based on a principle published 
by Belon and Frick [141]. Two RNA strands (from Henning Christian, our group), 
one of which was labeled with a fluorescent dye Cyanine 5 (Cy5) at the 5’-end and a 
Black Berry Quencher 650 (BBQ) at the 3’-end, were annealed together. Upon 
excitation at 643 nm, Cy5 emits light at 667 nm. If a strand separation of the 
annealed RNA occurs, the labeled RNA oligonucleotide would form a stable hairpin 
structure in which the fluorophore Cy5 becomes very close to the quencher BBQ, 
thus the fluorescent signal is reduced. Hence, the rate of the signal decrease is 
directly proportional to the rate of strand separation stimulated by the RNA 
helicase. The sequence of the two RNA oligonucleotides and the mechanism of this 
reaction are provided in Figure 2.3.  
 
Figure 2.3: Mechanism of the helicase assay. The dsRNA substrate consists of a non-labeled strand 
(black) and a Cy5- and BBQ-labeled strand (cyan). The strand separation causes the labeled strand to 
form a stable hairpin structure in which the dye Cy5 gets close to the quencher BBQ and thus quenches 
the signal. 
    0.1 µM eIF4A was mixed with 0.5 µM RNA into buffer containing 20 mM 
HEPES/NaOH, pH 7.0, 100 mM NaCl, 2 mM MgCl2, with total volume of 150 µl. 
Mixture was incubated at 20 ℃ in the dark for 15 min and measurement was 
started by addition of ATP to a final concentration of 1 mM. The excitation 
wavelength was set to 643 nm and the fluorescence change at 667 nm was recorded 
every two seconds for 10 min.  
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2.3.12 RNA sequences 
Table 2. 21: Sequences of RNAs used in this thesis 
Name Sequence Company 
poly(A)5 pAAAAA IBA 
poly(A)10 pAAAAAAAAAA IBA 
poly(A)15 pAAAAAAAAAAAAAAA IBA 
poly(A)20 pAAAAAAAAAAAAAAAAAAAA IBA 
ssRNA15161 pUGAGGUAGUAGGUUGUAUAGUU Roche 
ssRNA15162 pUUGUCUCUGGUCCUUACUU Roche 
ssRNAa-eGFP pCAGGUAGUGGUUGUCGGGCAG Roche 




dsRNA  pCAGGUAGUGGUUGUCGGGCAG 
GAGUCCAUCACCAACAGCCCGp 
Roche 
2.4 Crystallization and data collection 
2.4.1 Initial crystallization screens 
Initial screening of crystallization conditions was performed using sitting drop 
vapor diffusion technique. 0.25 µl of proteins were pipetted into 96-3-well MRC 
plates (Jena Bioscience) and mixed with either 0.25 µl (1:1) or 0.125 µl (2:1) of the 
reservoir solution using a Phoenix RE pipetting robot (Art Robbins Instruments). 
The volume of the reservoir is 35 µl. In total, 11 commercially available screens 
(listed in Table 2.22) at 4 ℃ and 20 ℃ have been tested for each protein or complex.  
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Table 2.22: Initial crystallization screens. Each screen contains 96 different conditions 
Name Supplier 
Ammonium sulfate Suite Qiagen 
JBScreen Classic (1, 2, 4, 5) Jena BioScience 
JBScreen Classic (6, 7, 8, 10) Jena BioScience 
JBScreen Nuc-Pro HTS (1, 2, 4, 5) Jena BioScience 
JCSG+ Suite  Newman et al. (2005) [142] 
MIDAS  Molecular Dimensions 
MIDAS diluted (0.5×) Molecular Dimensions 
Morpheus Molecular Dimensions 
Natrix HT Hampton Research 
PGA Molecular Dimensions 
Proplex Radaev et al. (2006) [143] 
2.4.2 Optimization of crystals 
Initial hits were usually optimized manually. Commercial “Additive Screen” 
(Hampton Research), “Silver Bullets Screen” (Hampton Research) as well as “pH 
buffer screen” (Emerald Bio) were routinely tested to improve crystallization 
conditions. The concentration of the precipitants and the their types were also 
varied. 
2.4.3 Data collection 
Crystals were fished with appropriate nylon loops. Prior to being exposed to X-ray, 
they were transferred into the cryo-protectant buffer (typically crystallization 
condition supplemented with 20-30 % (v/v) of glycerol or ethylene glycol) for 5 
seconds to 1 min and then flash cooled into liquid nitrogen. Diffraction of crystals 
was tested at a laboratory X-ray source (X-ray diffractometer MicroMaxTM-007 HF, 
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Rigaku), and those giving highest resolution were selected for data collection in 
synchrotron. The exposure time for testing experiments was usually 15 min and 
with 1° rotation. Diffraction datasets were collected at 100 K at beamline P13, 
PETRA III, DESY (Hamburg, Germany) and at beamline 14.1, BESSY II (Berlin, 
Germany, (Mueller et al. 2012)). 
2.5 Structure determination and refinement 
Diffraction data of C. thermophilum eIF3b were processed and scaled using the 
programs XDS and XSCALE [144]. Phase calculations and determination were 
carried out by using the SHELX suite [145]. Se positions were further refined using 
SHARP [146] followed by density modification by Solomon [147]. An initial 
poly-alanine model was built by ARP/wARP [148] and refined against Se-Met data 
with Refmac5 [149,150], which was used for manual rebuilding and sequence 
assignment in Coot [151]. Due to the lack of isomorphism between Se-Met and 
native crystals (the c axis differs in length by 14.7 Å, see Table 3.1), this initial 
model of the cteIF3b WD40 domain was positioned by molecular replacement into 
the unit cell of the native crystal. Further model optimization and completion has 
been performed against the native data. Prior to structural refinement, randomly 
selected 5% test set of the reflections were set aside for the calculation of Rfree as a 
quality monitor [152,153]. Refinement was performed with the PHENIX package 
[154]. The electrostatic surface potential was calculated with PDB2PQR [155] and 
displayed using the APBS plugin [156] of the PyMol software. 
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3 
Results 
3.1 Eukaryotic translation initiation factor 3 (eIF3) 
Depending on the organism eukaryotic translation initiation factor 3 (eIF3) contains 
in up to 13 non-identical subunits (eIF3a-m). In this thesis, only the simpler 
five-subunit functional core complex, consisting of eIF3a, b, c, g and i, has been 
mainly investigated. All the five subunits are universally conserved and essential 
for translation in vivo [42]. In addition to the functional core, the subunit j (eIF3j), 
which is involved in both translation initiation and post-termination, has also been 
extensively studied. All constructs (including full-length and truncations) of eIF3 
subunits designed and studied in this thesis are summarized in Figure 3.1. Notably, 
besides eIF3 subunits form Saccaromyces cerevisiae, Chaetomium thermophilum 
proteins were chosen as the objects of study. The reason for this is described in 
detail in Section 4.1. Generally, it is observed that thermophilic proteins are more 
stable and easier to crystallize compared to their mesophilic orthologs. 
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Figure 3.1: Diagram illustrating the designed constructs of eIF3 subunits. The boundaries of the 
constructs are indicated. Constructs design is based on secondary structure prediction, sequence 
conservation and functional domains. 
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3.1.1 Preparation of eIF3 subunits  
3.1.1.1 Purification of eIF3a, b, c, g and i 
All subunits of C. thermophilum eIF3 (cteIF3) core and their variants (Figure 3.1) 
(except eIF3g26-150 and eIF3g26-286, Δ151-179), of which the affinity tag(s) are listed in 
Table 2.12, could be overexpressed individually in E. coli BL21 (DE3) and    
Rosetta 2 (DE3) cells. They could also be purified independently to high purity with 
the exception of eIF3a and eIF3b167-704 (Figure 3.2, 3.3) (for detailed protein 
purification strategies for each protein refer to 2.2.2.7). eIF3a requires eIF3c or/and 
eIF3b to pass through the gel filtration column, while eIF3b167-704 needs eIF3i to get 
rid of the degraded products (Figure 3.3 A). Interestingly, a truncated eIF3b 
(eIF3b167-746) forms a dimer (Figure 3.3 B), whereas full-length eIF3b and its other 
truncations behave as a monomer as revealed by the size exclusion chromatography 
(SEC). All other subunits exist as monomers in solution. The yield for eIF3a and 
eIF3c was ~2-3 mg protein per liter of cell culture, whereas ~10, ~20, ~50 mg 
protein per liter of culture could be obtained in the case of eIF3g, eIF3b and eIF3i, 
respectively. 
 
Figure 3.2: Coomassie-stained SDS gels show full-length eIF3b, c, g and i subunits after the gel 
filtration (as the last purification step) and full-length eIF3a from Heparin column. Before the gel 
filtration, subunits b, c, g and i were independently purified using a GSTrap affinity column followed by 
a Source 30Q for eIF3b and SP Sepharose for eIF3g. Prior to Heparin, eIF3a was passed through a 
HisTrap column. eIF3a and eIF3c were purified by Bernhard Kuhle. 
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Figure 3.3: Purification of eIF3b167-704/eIF3i complex (A) and eIF3b167-C (B). The left panels show the 
profile of the Superdex 200, while the right panels show the corresponding Coomassie-stained SDS gels. 
eIF3i only binds to the stable and complete eIF3b167-704 but not the degraded eIF3b167-704. eIF3b167-C 
behaves as a dimer. However, the dimerization did not occur in the case of full-length eIF3b and all other 
truncations. 
3.1.1.2 Purification of eIF3j 
Both S. cerevisiae eIF3j (sceIF3j) and C. thermophilum eIF3j (cteIF3j) were 
overexpressed in E. coli cells. After the GSTrap affinity column, a Source 30Q ion 
exchange chromatography was necessary to remove impurities. sceIF3j (29.6 kDa) 
and cteIF3j (30.8 kDa) eluted at the volume of ~140 ml on the Superdex 200 (26/60) 
column, corresponding to a molecular weight of ~240 kDa (Figure 3.4 A). This 
indicates that eIF3j orthologs behave as octamers in solution. However, the 
multi-angle light scattering (MALS), which is more precise than SEC, demonstrated 
that eIF3j orthologs form dimers in solution (Figure 3.4 B).  
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Figure 3.4: Purification of eIF3j. (A) Size exclusion chromatography (SEC) of cteIF3j. eIF3j orthologs 
behave as octamers on the Superdex column. The corresponding Coomassie-stained SDS gel is shown on 
the right panel. (B) Multi-angle light scattering (MALS) of cteIF3j, identifying 64 kDa (dimer size) 
molecular mass.  
3.1.1.3 Formation of eIF3b-RRM/eIF3j complex 
The interaction between eIF3b and eIF3j has been determined by biochemical 
probes and structural studies [47,157]. The complex structure of human eIF3b-RRM 
(residues 197-274) and eIF3j (residues 45-55) revealed that the unstructured eIF3j 
loop binds to the α-helical surface of eIF3b’s RRM domain. In some cases, proteins 
in complexes with their interacting partners could be easier crystallized. Thus the 
minimal complex composed of S. cerevisiae eIF3b-RRM domain (residues 70-170) 
and sceIF3j was reconstituted in vitro. The formation of eIF3b74-170/eIF3j complex is 
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salt-dependent as less than 200 mM NaCl resulted in heavily precipitation, but 
more than 300 mM NaCl caused dissociation. Nevertheless, this complex could be 
assembled in vitro (Figure 3.5). 
 
 
Figure 3.5: Purification of sceIF3b-RRM/sceIF3j complex. The left panel shows the profile of the SEC, 
while the right panel shows the corresponding Coomassie-stained SDS gel. Prior to loading onto the 
Superdex 75 column (26/60), purified eIF3j and eIF3b74-170 were mixed with a molar ratio of 1:1 and 
incubated for 30 min. 
3.1.2 Interaction studies and complexes formation  
3.1.2.1 Reconstitution of eIF3 functional core complex 
Once proteins of individual C. thermophilum eIF3 subunits were obtained, the 
formation of eIF3 core complex and of its subcomplexes were tested. Subunits a, b, c, 
g and i of eIF3 form a stable complex as shown by means of analytic SEC (Figure 3.6 
A). The five-subunit complex eluted at 9.56 ml from the Superdex 200 (10/300), 
corresponding to a molecular weight of ~450 kDa. In addition, two distinct 
eIF3b-containing subcomplexes, eIF3a-b-c and eIF3b-g-i, have been assembled in 
vitro (Figure 3.6 B, C), indicating eIF3b serves as the major scaffold protein. 
However, in contrast to yeast eIF3 [59], a stable eIF3b-c-i-g subcomplex could not be 
reconstituted in vitro from C. thermophilum proteins (Figure 3.6 D).  
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3.1.2.2 Mapping the interacting regions in eIF3b-g-i subcomplex 
It has been demonstrated that the C-terminal ~100 amino acids of eIF3b are 
required for the interaction with eIF3g and i [44,48]. Associations with eIF3g and i 
are mutually beneficial rather than mutually exclusive, which indicates that the 
binding sites of eIF3b for eIF3g and i are not the same [48,59]. The crystal structure 
of yeast eIF3i and a C-terminal ~40-residue α-helix of eIF3b determined the 
residues for the interaction with eIF3i [48]. However the knowledge of the specific 
binding region for eIF3g is particularly lacking. Thus, different constructs were 
designed and subcloned (Figure 3.1). eIF3b167-704 is able to bind to eIF3i 
(Figure 3.7 A) but not to eIF3g (Figure 3.7 C) as reflected by the analytical SEC. In 
order to associate with eIF3g, the last 42 residues of eIF3b (eIF3b167-C) are 
necessary (Figure 3.7 B). However, the interaction between eIF3b167-C and eIF3g 
seems to be not really strong, since only weak eIF3g bands were observed in the 
SDS gel (Figure 3.7 B). Nevertheless, it is clear that the eIf3g binding site of eIF3b 
is located sequentially behind the binding site for eIF3i. Additionally, the GST 
pull-down experiment showed that the WD40 domain of eIF3b (eIF3b167-C) could 
neither interact with eIF3i (Figure 3.7 D, lane 8), eIF3g (Figure 3.7 D, Lane 12) nor 
eIF3i/eIF3g complex (Figure 3.7 D, lane 10). 
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Figure 3.6: Analytical size 
exclusion chromatography profiles 
of the five-component cteIF3 core 
(A), the cteIF3a-b-c subcomplex 
(B), and the cteIF3b-i-g sub- 
complex (C), respectively. The 
corresponding SDS-PAGE gels 
are shown on the right panel. (D) 
Overlay of the analytical SEC 
profiles of the cteIF3b-i-g sub- 
complex (dotted black), cteIF3c 
(dashed gray) and the cteIF3b-i-g 
subcomplex together with subunit 
c (solid dark). In case of cteIF3c + 
cteIF3b-i-g, two overlapping 
peaks are observed; the main peak 
at a higher elution volume cor- 
responds to eIF3c alone, whereas 
the smaller peak at a lower elution 
volume (forming the shoulder of 
the eIF3c peak) corresponds to the 
cteIF3b-i-g complex. A shift to a 
lower elution volume does not 
occur, indicating that the complex 
cteIF3b-i-g-c is not formed. 
Complex eIF3a-b-c was assembl- 
ed by Bernhard Kuhle. 
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(D) GST pull-down assays of full-length eIF3b, eIF3b-WD40, eIF3i, and eIF3g. Lanes 1-5 present the 
individual proteins as a reference and lane 6 is the marker labeled on the right side. Lanes 6-12 refer to 
the elution of the protein(s) after extensive washing. 
Figure 3.7: Mapping the inter- 
acting region of eIF3b for eIF3i 
and eIF3g. (A) Overlay of the 
analytical SEC profiles of 
cteIF3b167-704 (dotted black), 
cteIF3i (dashed gray) and their 
mixture (solid dark). Compared 
with individual proteins, a 
significantly shifted peak (towards 
small elution volume) was 
obtained, suggesting the formation 
of the complex eIF3b167-704-eIF3i. 
On the right panel an SDS gel of 
the complex in the shifted peak is 
shown. (B) Overlay of the 
analytical SEC profiles of 
eIF3b167-C (dotted black), eIF3g 
(dashed gray) and their mixture 
(solid dark). Instead of one single 
peak, eIF3b167-C shows two peaks 
of which one at ~10.7 mL corres- 
ponds to the dimeric protein and 
another at ~13.8 mL represents the 
monomeric eIF3b167-C. In the case 
of the mixture, the peak shift is 
obvious for mono-eIF3b167-C/g 
complex but not for di-eIF3b167-C/g 
complex due to the unfavorable 
separation of large molecule by 
analytical SEC. On the right side, 
SDS- PAGE reveals the formation 
of eIF3b167-C-g complex. (C) 
Overlay of the analytical SEC 
profiles of cteIF3b167-704 (dotted 
black), cteIF3g (dashed gray) and 
a mixture of both (solid dark) 
without any considerable shift. 
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3.1.3 Crystallization and structure determination of eIF3 
subunits and subcomplexes 
3.1.3.1 Crystals of eIF3j 
Needle-shaped crystals of full-length S. cerevisiae eIF3j appeared in conditions 
containing 1.7-2.5 M (NH4)2SO4, 0.05 M either MES, Sodium Cacodylate, MOPS or 
HEPES buffer, pH 5.6-7.5, at 20 °C (Figure 3.8 A). Unfortunately, optimization did 
not lead to improved crystals that diffracted. Additionally, in the condition that 
contains 12.5% and 15% PEG 3350, 0.1-0.3 M NaCitrate, pH 7.0, promising 
crystal-look precipitation came out approximately after two weeks (Figure 3.8 B, C). 
Similar to those needle shaped crystals, these ‘crystals’ could not be improved. Since, 
except the middle compact α-helical domain, eIF3j harbors long flexible tails at both 
N- and C-terminuses (each consisting of ~50 amino acids), a construct (sceIF3j56-218) 
that lacks the N- and C-tails was cloned. Crystals of sceIF3j56-218 were also obtained 
in the same conditions where the full-length protein was crystallized (Figure 3.8 D). 
These crystals could not be optimized, neither. Extensive efforts were also made to 
crystallize C. thermophilum eIF3j but were not successful. Great difficulty in 
getting good crystals of eIF3j is consistent with its behavior on the size exclusive 
chromatography. Homo-dimeric eIF3j elutes at a volume corresponding to an 
octamer, indicating large regions of eIF3j are not structured. Extended flexible 
regions are known usually to impair the crystallization. 
 
 
Figure 3.8: Crystals of full-length sceIF3j (A, B, C) and sceIF3j56-218 (D). Crystals in (A) and (D) grew 
in condition that contained 1.7-2.5 M (NH4)2SO4, 0.05 M either MES, Sodium Cacodylate, MOPS or 
HEPES buffer, pH 5.6-7.5. Crystals in (B) and (C) grew in condition containing 12.5-15% PEG 3350 
and 0.1-0.3 M NaCitrate, pH 7.0 
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3.1.3.2 Crystallization of eIF3b74-170/eIF3j subcomplex 
Crystallization of sceIF3b74-170/sceIF3j complex yielded crystals in a condition 
containing 20% polyethylene glycol 3350 and 0.2 M sodium thiocyanate (Figure 3.9). 
Based on their fragile feature, we can infer these crystals are protein crystals. 




3.1.3.3 Crystallization and structure determination of eIF3b 
Initial crystals of cteIF3b were obtained at 20 °C in a condition containing 15% (w/v) 
polyethylene glycol (PEG) 20k, 0.08 M MnCl2, 0.1 M MES, pH 6.5 after 
approximately 15 days (Figure 3.10 A). Optimization led to gradually improved 
crystals (Figure 3.10 B-D). Optimized native crystals diffracted to a resolution of 
2.7 Å and belong to the space group P43212. Molecular replacement (MR) attempts 
using 7- and 8-bladed β-propellers and fragments of them, as well as the RRM 
domains of human and yeast eIF3b did not result in any promising solutions. 
Therefore selenomethionine (SeMet) derivative crystals were produced (Figure 3.10 
E-H). SeMet crystals emerged under the same conditions that native crystals grew 
and diffracted to a resolution of 3.3 Å. SeMet crystals also belong to space group 
P43212. The phase problem was then solved using diffraction datasets collected at 
peak, inflection and remote wavelengths. Six out of seven expected selenium atoms 
were found by SHELXD.  
Figure 3.9: Crystals of 
sceIF3b74-170/sceIF3j complex. 
Crystals grew in a condition 
containing 20% polyethylene 
glycol 3350 and 0.2 M sodium 
thiocyanate. 
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Figure 3.10: Crystals of native cteIF3b (A-D) and SeMet cteIF3b (E-H). All crystals grew in a condition 
that contained 15% (w/v) PEG 20k, 0.08 M MnCl2, 0.1 M MES, pH 6.5. 
 
    The final model was refined at a resolution of 2.7 Å with Rfactor = 20.6%, Rfree = 
23.0% (Table 3.1). However, it comprises only the WD40 domain of cteIF3b (residues 
165-638) rather than the full-length protein. Moreover, one loop region (residues 
299-311) was not defined in the electron density map. This strongly indicated that 
specific cleavages by contaminating proteases occurred during the crystallization. 
This indication has been supported by an SDS-PAGE of the dissolved crystals, 
which revealed a discrete band corresponding to a molecular weight of ~55 kDa that 
is consistent with the size of the WD40 domain instead of the expected band for the 
86 kDa full-length cteIF3b (Figure 3.11).  
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3.1.3.4 Crystallization of eIF3b-g-i complex 
Although the protein of eIF3b-g-i subcomplex was highly pure (Figure 3.6 C), no 
promising crystallization hits were found. Crystallization trials of 
eIF3b167-C/eIF3i/eIF3g, eIF3b167-704/eIF3i and eIF3bFL/eIF3i were also performed. 
However, no crystals of them were obtained. 
  
Figure 3.11: SDS-PAGE of 
full-length cteIF3b, cteIF3b WD40 
domain and dissolved crystals. The 
molecular weight of full-length 
cteIF3b and its WD40 domain are ~90 
kDa and ~55 kDa, respectively. The 
size of the crystallized fragment is the 
same as cteIF3b WD40 domain. 
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Table 3.1: Data collection and phasing statistics 
 
 SeMet-derivative, MAD Native 
Peak Inflection Remote  
Data collection 
Wavelength (Å) 0.9798 0.9799 0.9775 0.8266 
Space group P43212 P43212 P43212 P43212 
























Unique reflections 32904 (2863) 31367 (2719) 30923 (2659) 28259 (2828) 
Redundancy 3.1 (2.9) 3.1 (3.0) 2.7 (2.7) 8.5 (8.6) 
Completeness (%) 98.2 (98.9) 98.0 (98.7) 97.9 (98.6) 99.9 (100.0) 
Rmerge (%) 9.2 (73.8) 9.0 (61.0) 9.5 (60.3) 5.7 (61.5) 
I/σ (I) 11.67(1.76) 12.45 (2.13) 10.71 (1.90) 25.67 (3.48) 
CC1/2 99.7 (66.5) 99.7 (74.5) 99.5 (67.7) 99.9 (92.0) 
Phasing 
Anomalous Corr. a 47 (4) 34 (11) 28 (12)  
SigAno a 1.33 (0.78) 1.16 (0.83) 1.08 (0.82)  
FOM after DM 0.573  
 
 
Values for the data in the highest resolution shell are shown in parentheses. 
a Anomalous correlation and mean anomalous difference (SigAno), calculated with XSCALE. 
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Table 3.2: Refinement statistics 
 
Structure refinement 
Resolution range (Å) 48.47-2.72 (2.82-2.72) 
Completeness (%) 100.0 (100.0) 
Rwork/Rfree (%)b  20.56/22.98 
No. of atoms   
   Total 3819 
   Protein 3764 
   Solvent 51 
   Ions 4 
RMSD bonds (Å) 0.003 
RMSD angles (º) 0.806 
B factor (Å2)  
   Average  74.8 
   Protein  75.0 
   Solvent 61.8 
    Ions 97.0 
Wilson B factor (Å2)c 66.87 
Solvent content (%) 73 
Ramachandran plot  
 Favored (%) 95.19 
 Allowed (%) 4.81 
 Outliers (%) 0.0 
 
 
Values for the data in the highest resolution shell are shown in parentheses. 
b Rfree = ∑Test||Fobs| –|Fcalc||/∑Test |Fobs|, where “Test” is a test set of about 5% of the total 
reflections randomly chosen and set aside prior to refinement for the complex. 
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3.1.4 Structural analysis of eIF3b-WD40  
3.1.4.1 Overall structure 
The WD40 domain of eIF3b has been predicted to fold into two tandem β-propellers 
[46]. Surprisingly, in contrast to the prediction, eIF3b-WD40 actually adopts a 
single β-propeller fold composed of nine blades (Figure 3.12). The nine blades are 
pseudo-symmetrically arranged in sequential order around a central channel, 
resulting in a doughnut-like architecture. Each blade of the propeller is formed by a  
 
 
Figure 3.12: Overall structure of cteIF3b-WD40. (A) Top, side and bottom view of the overall structure 
of cteIF3b-WD40 in cartoon representation. Blades 1-9 are colored individually. N- (N) and C-termini (C) 
are labeled. (B) Topology diagram of the cteIF3b β-propeller fold. The left and right drawing are shown 
in orientations similar to the side and bottom view in (A), respectively. 
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β-sheet consisting of four antiparallel strands, which are designated A, B, C and D 
from the inside to the outside of the propeller. Notably, the first blade of the 
propeller is composed of three N-terminal strands and a C-terminal strand 
positioned innermost, creating a “3N + 1C velcro” closure. Interestingly, the central 
channel of the nine-bladed cteIF3b WD40 propeller resembles a circular truncated 
cone rather than a common cylinder (Figure 3.12). The diameter of the channel 
decreases from 29.5 Å on the ‘top’ side to ~15.6 Å on the ‘bottom’ side. By contrast, 
the outermost shape of cteIF3b propeller is almost cylindrical. The overall diameter 
on the top and bottom side is 53.6 Å and 51.5 Å, respectively.  
3.1.4.2 Sequence and structural conservation of the WD40 repeats 
Structure-based sequence alignments of the WD40 repeats of cteIF3b reveal several 
conserved sequence characteristics, notably the Trp-X-Pro (where X represents any 
amino acid) motif at the end of strands A, and Phe/Tyr-Ф (where Ф stands for a 
hydrophobic amino acid) segment in strands B, as well as hydrophobic residues in 
strands D (Figure 3.13 A). However, the eponymous Trp-Asp (WD) dipeptide located 
at the ends of strands C is only present in blades 3 and 8. The Trp residue of the WD 
motif has been replaced by the aromatic amino acid Tyr (in blades 4 and 9), Phe (in 
blades 6 and 7) and the hydrophobic Met in blade 5, whereas the Asp has been 
substituted by other polar residues with the only exception of a Gly in blade 2 
(Figure 3.13 A).  
The repeating motifs (single blades) within the cteIF3b WD40 domain are 
structurally well conserved as well, with an root-mean-square deviation (r.m.s.d.) 
ranging from 0.94 Å to 1.57 Å for all Cα atoms, whose positions differed less then 
3 Å, when superimposing each blade onto blade 1 (Figure 3.13 B). 
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Figure 3.13: Sequence and structural conservation of eIF3b. (A) Sequence alignment of the nine 
β-sheets of cteIF3b-WD40. Residues are colored according to the conservation pattern (highly conserved: 
dark red; conserved: pink). Residues forming the β-strands are underlined and arrows on the top indicate 
the positions of strands A-D. (B) Superposition of the nine β-propeller blades of cteIF3b. The blades are 
colored as in Fig 1B. In the image on the right, the long β-sheet 6 was omitted for clarity reasons.  
3.1.4.3 Conservation of eIF3b orthologs 
Multiple sequence alignment reveals that eIF3b orthologs from different organisms 
vary considerably in the N-terminal domain, but are well conserved in the WD40 
domain as well as in the C-terminal part of the protein (Figure 3.14). Secondary 
structure predictions (using the PSIPRED server [158]) of eIF3b orthologs assign 
34-36 β-strands to their WD40 domains, indicating that the nine-bladed WD40 
β-propeller fold of cteIF3b is not a unique instance, but is employed universally by 
eIF3b orthologs. Many of the identical residues among the orthologs are 
hydrophobic and located in the structural core of the WD propeller (Figure 3.14), 
indicating their role in accurate folding and stability.  
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Figure 3.14: Multiple sequence alignment of eIF3b orthologs. Amino acid sequences of eIF3b from 
Chaetomium thermophilum (ct), Oryctolagus cuniculus (oc), Homo sapiens (hs), Mus musculus (mm), 
Schizosaccharomyces pombe (sp), and Saccharomyces cerevisiae (sc) are aligned using ClustalW2 
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(www.ebi.ac.uk/Tools/msa/clustalw2/, [159]). Identical residues are highlighted with blue background 
and conserved residues with cyan background. Secondary structure elements (β-strands: arrows; 
α-helices: rounded rectangles; loops: lines) are indicated above the alignment (residues that were not 
built in the structure are represented as dashed lines). The WD40 domain of eIF3b is colored as in Fig 
3.12B, while the N-terminal RRM domain and the C-terminal α-helix, which are not present in our 
structure, are colored with light gray. 
 
 
Figure 3.15: Surface representation of cteIF3b-WD40. (A) Surface representation of cteIF3b-WD40 
with sequence conservation represented in the color coding bar, ranging from cyan (variable) to purple 
(conserved). The conservation scores were generated by ConSurf (http://consurf.tau.ac.il/) using the 
sequence alignment of eIF3b-WD40 as shown in Figure 3.14. Highly conserved surface residues are 
labeled. (B) Electrostatic potential of conserved surface areas of cteIF3b-WD40. The electrostatic surface 
potential of cteIF3b-WD40 colored from red (-5kT/e) through white (0kT/e) to blue (+5kT/e). Areas 
containing conserved surface residues are encircled and labeled based on blade numbers or propeller side. 
The orientations are similar to (A). 
Additionally, two clusters of surface residues are highly conserved from yeast to 
humans (Figure 3.15 A), suggesting a potential role in binding other proteins and/or 
the other eIF3b domains. The first conserved surface region is located on the side of 
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conserved area is situated primarily on the top of the propeller involving residues 
from the AB loops of blades 9, 1, 2 and 3 and the D strands of blades 1 and 2 
(Figure 3.15 A). Interestingly, both conserved surface areas of cteIF3b-WD40 
mainly contain hydrophobic and positively charged residues, which could be 
involved in RNA-binding (Figure 3.15 B). 
3.1.5 Localization of eIF3b on the ribosome 
In the cryo-EM map of the rabbit 43S PIC bound to helicase DHX29 (EMDB code: 
5658), the interpretation of a doughnut-like density below the shoulder of the 40S 
subunit could not be verified. The 7-bladed β-propeller protein eIF3i was tried to fit 
there, however, the possibility that this density originated from the WD40 domain 
of eIF3b could not be excluded by the authors (Figure 3.16 A) [61]. Notably, this 
cryo-EM segment definitely possesses a channel with a wide top and narrow bottom. 
As aforementioned, the WD40 domain of eIF3b harbors a channel with similar 
geometric parameters, which reaches a consensus with the cryo-EM density on the 
axle outline (Figure 3.12 and 3.16 B,C). By contrast, eIF3i holds a channel that has 
a similar width on both sides (PDB code: 3ZWL) (Figure 3.17). Additionally, the 
overall size of eIF3i is too small to fully explain this EM density (Figure 3.17). Due 
to the lack of technical details, the fitting of eIF3i to the doughnut-like density could 
not be repeated and show a similar result as reported [61]. Our fit of eIF3i using 
Chimera 1.8 [160] resulted in a cross-correlation coefficient (CCC) of 0.52, and 38.5% 
atom outliers, respectively. The fitting statistics significantly improved when the 
WD40 propeller (without the non-conserved loops) of cteIF3b was positioned in the 
doughnut-like density (Figure 3.17), with a corresponding CCC of 0.91 and only 17% 
of the atoms outside the density. On the basis of our fit, blades 5 and 6 of the 
propeller are oriented towards the ribosomal protein S9e (rpS9e) and the ribosomal 
RNA helix h16, while the opposite side holding the N- and C-terminuses is solvent 
exposed (Figure 3.16 B,C). The position of eIF3b directly below the shoulder of the 
40S is in good agreement with previous studies. Two eIF3b binding domains 
(eIF3j-NTD and eIF3a-CTD) have been reported to bind to the 40S mRNA entry 
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Figure 3.16: Interaction of eIF3b with the 40S ribosomal subunit. (A-D) Localization of eIF3b on the 
40S subunit. The non-conserved loop insertions of cteIF3b-WD40, which are absent in rabbit eIF3b, 
were removed prior to fitting. In figure C and D, the density assigned to DHX29 was removed for clarity. 
(A) Overall view of the position of eIF3b-WD40 β-propeller on the 40S ribosomal subunit (EMDB ID: 
5658). eIF3b-WD40 (blue) is located below the shoulder of the 40S and is disconnected from the eIF3 
subcomplex containing the subunits a*, c, e, f, h, k, l, and m (cyan). The asterisk marks a truncated 
version of eIF3a. (B) Detail side view of eIF3b-WD40 localization. The rpS9e and the rRNA helix h16 
are indicated. (C) Top view of eIF3b-WD40 showing the characteristic conical central channel. (D) 
Structural model of a possible interaction between the eIF3b WD40 propeller and the 18S rRNA 
expansion segment ES6S-hA. The rRNA helix was manually fitted into the EM density portion using the 
crystal structure of the 40S ribosome (PDB code: 4KZZ). 19 nucleotides of ES6S-hA, which are missing 
in the crystal structure, have been modeled (colored green) to illustrate their potential extension.  
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Figure 3.17: Comparison of the final fit of eIF3b-WD40 (blue) and eIF3i (yellow, PDB code: 3ZWL). In 
figure A the density (assigned to DHX29) above the doughnut-like density was removed for clarity. 
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3.1.6 Interaction of eIF3b with the ribosome 
3.1.6.1 Interaction with the 40S ribosomal subunit 
Since a direct interaction between eIF3b and the 40S ribosomal subunit has so far 
not been reported, in vitro co-sedimentation assays were performed to verify the 
interpretation of the EM map (in collaboration with S. Schell and A. Chari). Purified 
C. thermophilum 40S ribosomal subunit was incubated with increasing amounts of 
cteIF3b and the mixtures were applied to sucrose gradients. The appearance of an 
additional ~86 kDa protein in the pellet, which is absent in sedimented pure 40S 
subunit, indicates that eIF3b stably associates with the 40S, while unbound eIF3b 
remained in the supernatant (Figure 3.18 A). Besides full-length eIF3b, a truncated 
eIF3b (eIF3b167-670, containing the WD40 domain plus a ~30-residue C-terminal 
extension) also binds to the 40S (Figure 3.18 B), which suggests that the N-terminal 
RRM domain of eIF3b is not necessary for the association of eIF3b and 40S.  
 
 
Figure 3.18: (A) Co-sedimentation of eIF3b and the 40S. eIF3b was co-sedimented with the 40S (Lanes 
2-6) and the excess eIF3b remains in supernatant (Lanes 2'-6'). Lanes 1 and 1' represent the 40S alone 
control. (B) Co-sedimentation of eIF3b167-670
 
and the 40S. eIF3b167-670
 
was co-sedimented with the 40S 
(Lanes 2-3) and the excess eIF3b167-670
 
remains in the supernatant (Lanes 2''-3''). Lane 1 and Lanes 2'-3' 
show the 40S alone and the protein alone control, respectively. 
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3.1.6.2 Interaction with the ribosomal protein S9e 
Since our interpretation of the 43S PIC EM-structure places eIF3b next to the 
ribosomal protein rpS9e, a possible interaction between these two proteins was 
analyzed by pull-down assays. Both full-length cteIF3b and the truncated version 
cteIF3b167-C bind to GST-tagged ctrpS9e (Figure 3.19 A), while the truncated 
proteins cteIF3b167-670 and cteIF3b167-704 do not (Figure 3.19 B). This implies that the 
42 C-terminal residues of cteIF3b are crucial for the interaction with ctrpS9e. 
Importantly, this interaction of the eIF3b-CTD is not a prerequisite for binding of 
eIF3b to the 40S ribosome, as cteIF3b167-670 is still capable to associate with 40S 
(Figure 3.18 B). Thus, interactions of the β-propeller with other parts of the 40S 
ribosome, e.g. the rRNA ES6S-hA, are sufficient for stable association (see 
Discussion 4.3).  
3.1.6.3 Formation of rpS9e-eIF3b-g-i complex  
As known, the eIF3b CTD also contains the binding sites for eIF3g and eIF3i. 
Whether the interaction between eIF3b and rpS9e affects the binding of eIF3g and 
eIF3i to eIF3b was further tested. The observed quaternary complex (Figure 3.19 A) 
suggests that these intermolecular interactions are not mutually exclusive. 
Consistently, the rpS9e binding site of eIF3b is located C-terminally to the α-helix of 
eIF3b interacting with the eIF3i β-propeller [48]. Interestingly, the NTD of eIF3b 
apparently also contributes to the formation of the rpS9e-eIF3b-g-i complex, as the 
N-terminal truncated eIF3b167-C exhibits a lower affinity to eIF3g, i (Figure 3.19 A). 
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Figure 3.19: (A) Interaction study between eIF3b and rpS9e by GST pull-down assay. Lanes 1-6 show 
the isolated proteins as a reference. Lanes 7-11 show the elution fractions of the GST pull-down after the 
removal of unbound proteins and extensive washing. rpS9eΔ corresponds to rpS9e1-183. (B) Interaction 
study between eIF3b truncations, eIF3i, eIF3g and rpS9e by GST pull-down assay. Lanes 1-5 show the 
single proteins as a reference. Lanes 12-14 show the elution fractions of the GST pull-down after the 





band in Lane 14, eIF3b167-704-eIF3i complex in Lane 13 indicate that rpS9e 
could not bind these three polypeptides or the interaction between them is too weak to be observed by 
GST pull down. The observed weak eIF3i and eIF3g band in lane 12 suggests that rpS9e is able to 
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3.2 Eukaryotic translation initiation factor 4 (eIF4) 
The heterotrimeric complex eIF4F consists of the cap recognition protein eIF4E, the 
ATP-dependent RNA helicase eIF4A and the large scaffold protein eIF4G. It works 
conjunction with eIF4B to activate the mRNA to be translated. eIF4B and eIF4G 
have been shown to enhance the ATPase and helicase activities of eIF4A (fore more 
details see Introduction 1.4). The aim of this section is to obtain the structural 
information of the mRNA activation complex and determine the underlying 
mechanism by which the ATPase and helicase activities of eIF4A are stimulated by 
eIF4G and eIF4B.  
3.2.1 Preparation and crystallization of the full-length 
eIF4F complex 
3.2.1.1 Purification of eIF4A, eIF4B and eIF4E 
The gene encoding full-length S. cerevisiae eIF4A was cloned into a modified 
pET15b vector that expresses a His6-tag at the N-terminus of eIF4A. S. cerevisiae 
eIF4B and S. cerevisiae eIF4E were individually fused with an N-terminal GST tag 
(pGEX-6P-1). All three relatively small proteins (eIF4A: 45kDa; eIF4B: 48kDa; 
eIF4E: 24kDa) could be overexpressed in E. coli cells. Both BL21 (DE3) and 
Rosetta 2 (DE3) strains were able to produce full-length eIF4A and eIF4E, but 
eIF4B could only be synthesized in Rosetta 2 (DE3) cells. In addition, overexpressed 
eIF4A seems to be toxic for the host cells. Thus, it was necessary to harvest the cells 
five hours after induction with IPTG (rather than overnight expression). All three 
full-length proteins could be purified to near homogeneity in an RNA free form 
using Ni-NTA affinity column (for eIF4A) or GST affinity column (for eIF4B and 
eIF4E) followed by a Source 30Q anion exchange step (eIF4A and eIF4B) (Figure 
3.20). All proteins behave as a monomer in solution as revealed by the gel filtration 
chromatography or multi-angle light scattering. It turned out that eIF4B is prone to 
degradation (Figure 3.20 B), and thus, it is necessary to add protease inhibitors 
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during the purification procedure. The yield for all three proteins was ~8 mg per 
liter of culture.  
 
 
Figure 3.20: Purification of eIF4A (A), eIF4B (B) and eIF4E (C). Coomassie-stained SDS gels show the 
samples after the gel filtration as the last purification step. Before gel filtration, eIF4A was purified using 
a Ni-NTA affinity column and a Source 30Q, while eIF4B and eIF4E were independently passed through 
a GST affinity column, and a Source 30Q for eIF4B. The tags were cleaved after the first affinity 
column. 
3.2.1.2 Expression and purification of full-length eIF4G 
Expression in bacterial cells   E. coli cells were first used to express 
S. cerevisiae eIF4G (107 kDa). The N-terminal GST fused full-length eIF4G could 
be expressed in E. coli Rosetta 2 (DE3) cells, albeit the yield was pretty low 
(~0.25 mg per liter of culture). However, this eIF4G was prone to degradation, and 
thus purification of the full-length protein failed (Figure 3.21 A). To obtain 
full-length eIF4G, a construct of eIF4G that possesses an N-terminal Strep tag as 
well as a C-terminal His6 tag was designed. This double tagged eIF4G was also 
expressed in E. coli Rosetta 2 (DE3) cells and could be purified to a state that only 
contain two impurities after the Strep-Tactin affinity and Ni-NTA affinity columns 
(Figure 3.21 B, C). Despite extensive work, it was not possible to obtain enough 
protein for an additional purification step (e.g. a size exclusion chromatography), 
and thus for crystallization trials as well as functional studies.  
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Figure 3.21: Purification of full-length eIF4G expressed in bacterial cells. (A) Size exclusion 
chromatography (SEC) of full-length eIF4G that was expressed with an N-terminal GST tag. The GST 
tag was removed between the GSTrap and SEC. The protein was severely degraded. (B) The Strep 
Tactin affinity chromatography of full-length eIF4G that was expressed with an N-terminal Strep tag and 
a C-terminal His6 tag. ‘C’: whole cell lysate; ‘S’: supernatant; ‘P’: pellet; ‘Ft’: flowthrough of Strep 
Tactin chromatography. (C) The HisTrap affinity chromatography after the Strep Tactin affinity 
chromatography. Full-length eIF4G could be purified to a state that only contains two impurity bands.  
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Expression in insect cells   Considering the limitations of bacterial protein 
expression, insect cells were tried to produce full-length S. cerevisiae eIF4G. Thus, 
The gene encoding eIF4G was cloned into a pFastBac HT B vector (Invitrogen) and 
a Bacmid DNA containing eIF4G gene was generated. Subsequently, this Bacmid 
DNA was transfected into Sf9 insect cells for virus generation and amplification 
(more details see 2.2.2.2). The protein was expressed (with an N-terminal His6 tag) 
for various times after infection with different ratios of virus to cells as shown by 
SDS-PAGE (Figure 3.22). Large-scale expression was done in High Five cells.  
 
 
Figure 3.22: Coomassie-stained SDS gels showing expression of full-length eIF4G in insect cells. (A) 
Test experiment of the amount of virus. ‘inf’: infected; ‘no’: no infection. In this case, the amount of 
virus did not really affect the level of expression. (B) Expression time course of full-length eIF4G. eIF4G 
starts to be expressed after 24 h of infection (1:300), and the expression increases along with time. 
Usually, the cells were harvested after 36 h infection, taking into consideration of the total amount of the 
living cells and stability of expressed full-length eIF4G. 
    After systematic purification optimization, full-length eIF4G could be prepared 
with high purity using the HisTrap column followed by SP sepharose and gel 
filtration chromatography (Figure 3.27). To completely get rid of contaminations 
(including proteins and RNAs), the sample was extensively washed with high salt 
(500 mM NaCl and 1 mM LiCl) containing buffer (details see 2.2.2.7). 
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Figure 3.23: Purification of full-length eIF4G expressed in insect cells. (A), (B) and (C) 
Coomassie-stained SDS gels showing samples from HisTrap, SP Sepharose and Size exclusion 
chromatography (SEC), respectively. ‘C’: whole cell lysate; ‘S’: supernatant; ‘P’: pellet; ‘Ft’: 
flowthrough; ‘Inp’: input. The profile of HisTrap chromatography is similar to Figure 3.21 B, while the 
chromatograms of SP Sepharose and SEC are shown in (D) and (E), respectively. Full-length eIF4G 
elutes from the Superdex 200 (16/300) at ~9.7 ml. 
3.2.1.3 Preparation of the full-length eIF4F complex 
Since full-length eIF4G is difficult to obtain, in the case of preparing eIF4F complex 
(consisting of eIF4E, eIF4G and eIF4A), we applied a special purification strategy to 
reduce the loss of the protein during purification. We used purified GST tagged 
eIF4E as the ‘bait’ to fish eIF4G that was supplied with purified eIF4A. As shown by 
the SDS gel (Figure 2.24 A), these impurities that are associated with eIF4G and 
excess eIF4A eluted in the flowthrough, while the GST fused ternary eIF4F complex 
and GST-eIF4E eluted in buffer containing 35 mM reduced Glutathione. The GST 
tag was removed by PreScission protease and finally separated by a Superdex 200 
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Figure 3.24: Purification of full-length eIF4F complex. (A) Affinity purification of full-length eIF4G 
supplied with purified eIF4A, using purified GST-eIF4E that binds to the GSTrap column. The left panel 
shows the chromatogram, and the right panel shows corresponding the SDS-PAGE gel. Impurities and 
excess of eIF4A were eluted in flowthrough (Lane 5), while the GST fused ternary eIF4F complex and 
excess GST-eIF4E were eluted in elution buffer. (B) Size exclusion chromatography of full-length eIF4F 
complex. The Superdex 200 (16/60) chromatogram is shown on the left panel, and the SDS-PAGE gel is 
exhibited on the right panel.  
3.2.1.4 Crystallization of the eIF4F complex 
Although pure full-length eIF4F complex was obtained finally, crystallization trials 
with 4.5 mg/ml and 8 mg/ml protein at 4 and 20 °C yielded no promising hits. All 
eleven crystallization screens (Table 2.22) were tested. 
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3.2.2 Preparation of minimal functional eIF4F complex 
Secondary structure prediction of eIF4G shows that this protein is largely 
unstructured, especially two thirds of the N-terminal region. The reason that 
crystallization of full-length eIF4G and the eIF4F complex was failed might be due 
to the highly flexible regions of eIF4G. Therefore, systematically screenings for 
soluble fragments encompassing the eIF4E and/or eIF4A binding regions (Figure 
3.25) were performed. Among the 17 different constructs, 12 could be expressed in 
E. coli cells (indicated with ticks), 7 could be purified (labeled with two ticks).  
 
 
Figure 3.25: Diagram illustrating the designed constructs of sceIF4G. The boundaries of the constructs 
are given. Constructs design is based on secondary structure prediction, sequence conservation and 
functional domains. Among the 17 different constructs, 12 could be expressed in E. coli cells (indicated 
with ticks), and 7 could be purified (labeled with two ticks). These constructs without tick could not be 
expressed in E. coli cells. eIF4GM: containing the minimal eIF4A-binding domain only; eIF4GsN-M-sC: 
containing the minimal eIF4A-binding domain and short N- and C-terminal tails; eIF4GNM: containing 
the minimal eIF4A-binding domain and the adjacent basic residue-rich fragment. 
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3.2.2.1 Activities of eIF4A stimulated by eIF4G and eIF4B 
It is known that full-length eIF4G is able to enhance the ATPase and helicase 
activities of eIF4A. To characterize whether the purified truncations of eIF4G still 
possess the stimulation ability and to further investigate the underlying mechanism 
of the stimulation, real-time ATPase activity assays were first performed. 
ATPase activity 
The ATPase activity was carried out using the EnzCheck® Phosphate Assay kit 
(Invitrogen) which quantitatively detects the inorganic phosphate (Pi) that is 
released upon ATP hydrolysis (see Section 2.3.10). In each reaction, 1 µM protein(s) 
and 5 µM 22-nucleotide single stranded RNA (ssRNA15161, Table 2.21) were used. 
Consistent with previous studies, eIF4A alone exhibits very low ATP hydrolysis 
activity (Figure 3.26, blue). Interestingly, eIF4G572-853 (later called eIF4GM: 
containing the minimal eIF4A-binding domain only) did not stimulate the ATPase 
activity of eIF4A as reported before [108] (Figure 3.26, red). This might be due to 
the different methods used (see Discussion 4.5). Because of the extremely low 
enzymatic activity in the case of apo eIF4A and eIF4A/eIF4GM, it is impossible to 
reach the saturation and thus evaluate the kinetic statistics.  
Except eIF4GM, the remaining 6 purified eIF4G truncations (Figure 3.25, 
labeled with two ticks) stimulate the ATPase activity of eIF4A to different extents. 
In the primary round of experiments, the representative eIF4GM, eIF4G468-853 and 
eIF4G542-883 were chosen for determining the kinetic parameters, and thus for 
systematic comparison. eIF4G468-853 (later called eIF4GN-M) contains the minimal 
eIF4A-binding domain and the adjacent N-terminal fragment , while eIF4G542-883 
(later called eIF4GsN-M-sC) contains the minimal eIF4A-binding domain flanked by 
short fragments at both N- and C-termini. In the presence of eIF4GN-M (Figure 3.26, 
green), the maximal velocity (Vmax) of the ATP hydrolysis by eIF4A is 6.09 ± 0.12 
µM·min-1, while the KM and kcat/KM are 94.13 ± 6.13 µM and 0.065 µM-1·min-1, 
respectively (Table 3.3). Compared to eIF4GN-M, the stimulation ability of 
eIF4GsN-M-sC (Figure 3.26, black) is weaker. Notably, the estimated kinetic 
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Figure 3.26: The ATPase activity was determined using the EnzCheck® Phosphate Assay kit (Invitrogen) 
which quantitatively detects the inorganic phosphate (Pi) that is released upon ATP hydrolysis. ATPase 
activity of eIF4A (blue), eIF4A/eIF4GM (red), eIF4A/eIF4B (yellow), eIF4A/ eIF4GsN-M-sC (black), 
eIF4A/eIF4B/eIF4GsN-M-sC (gray), eIF4A/eIF4GN-M (green), eIF4A/eIF4B/eIF4GN-M (magenta). In each 
reaction, 1 µM protein(s) and 5 µM 22-nucleotide ssRNA15161 (see Table 2.21) were used. Every reaction 
was measured at least three times. The circles represent the mean value, and the error bars indicate the 
standard deviations. 
Table 3.3: Kinetic parameters describing the ATPase activity of eIF4A/eIF4B/eIF4GN-M, 
eIF4A/eIF4GN-M, eIF4A/eIF4B/eIF4GsN-M-sC, eIF4A/eIF4GsN-M-sC. 
 4A+4B+4GM 4A+4GM 4A+4B+4GsN-M-sC 4A+4GsN-M-sC * 
Vmax (µM·min-1) 6.77±0.10 6.09±0.12 5.92±0.10 10.69±1.10 
KM (µM) 50.11±2.84 94.13±6.13 128.88±6.94 1535.6±235.5 
kcat (min-1) 6.77±0.10 6.09±0.12 5.92±0.10 10.69±1.10 
kcat/KM (µM-1·min-1) 0.135 0.065 0.046 0.007 
*: in the case of eIF4A/eIF4GsN-M-sC, the evaluated kinetic parameters are questionable due to the 
limitation of the low activity.  
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    Intriguingly, eIF4B alone showed no effect on the ATPase hydrolysis rate of 
eIF4A at all, but addition of eIF4B to eIF4A/eIF4GN-M and eIF4A/eIF4GsN-M-sC 
induced a further enhancement (Figure 3.26, magenta and gray). The Vmax of 
eIF4A/eIF4GN-M increased from 6.09 ± 0.12 µM·min-1 to 6.77 ± 0.10 µM·min-1 by 
eIF4B, while the KM decreased from 94.13 ± 6.13 µM to 50.11 ± 1.84 µM (Table 3.3). 
Thus, in the presence of eIF4B, the kcat/KM value was elevated additionally ~2-fold 
relative to that of eIF4A/eIF4GNM, indicating higher enzymatic efficiency. 
Helicase activity 
The RNA unwinding activity of eIF4A was tested in the absence and presence of 
eIF4B, eIF4GN-M and eIF4GsN-M-sC, using a fluorescence-based assay (see Section 
2.3.11). However, no helicase activity was detected for all samples (data not shown). 
This might be due to the RNA substrate (originally designed for the helicase Prp43 
[163]), which is not appropriate for eIF4A (see Discussion 4.4).  
3.2.2.2 RNA-binding ability of eIF4A and eIF4G variants 
Electrophoretic mobility shift assays (EMSA) were performed to study the potential 
RNA-binding capability of eIF4G variants, and eIF4A. In the presence of eIF4A, the 
22-nucleotide single stranded RNA15161 (see Table 2.21) migrated slightly slower in 
the agarose gel (Figure 3.27, Lane 2), consistent with previously reported weak 
RNA-binding affinity of eIF4A. eIF4GN-M, eIF4GsN-M-sC and eIF4GM alone showed 
strong, medium and weak effect on the RNA migration, respectively (Figure 3.27, 
Lane 3-5). Reduced effects on the migration of RNA were observed when eIF4G 
variants were in complex with eIF4A (Figure 3.27, Lane 6-11). However, this does 
not mean eIF4A/eIF4G complexes possess lower RNA-binding ability because the 
total charge state of the complexes also impairs RNA migration. Nevertheless, it is 
obvious that the RNA-binding capability reflected by the influence on RNA 
migration corresponds to the enzymatic stimulation ability. Stronger RNA-binding 
reflects stronger enhancement on ATPase activity, and vice versa (Section 3.2.2.1). 
In addition, the RNA-binding ability of eIF4A/eIF4G complex is shown to be 
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nucleotide independent. Almost identical shifts were observed in the cases of 
addition of AMPPNP and ADP (Figure 3.27) 
 
    Assuming that the stimulating effect of eIF4G is achieved through providing 
RNA for eIF4A, the ATP hydrolysis rate of eIF4A alone should increase if eIF4A has 
higher accessibility to RNA substrates. Therefore, the ATPase activity of eIF4A 
itself was tested in the presence of ssRNA15161 with increasing concentrations. The 
data showed that the ATP hydrolysis rate of eIF4A was elevated 2- and 3-fold as the 
RNA concentration rose from 5 µM to 36 µM and 100 µM, respectively (Figure 3.28). 
 
Figure 3.27: EMSA of ssRNA15161 
supplied with eIF4A and/or eIF4G 
variants. Consistent with the ATPase 
activity stimulation level, eIF4GN-M, 
eIF4GsN-M-sC and eIF4GM show strong, 
medium and weak effect on RNA 
migration, respectively. In each case, 
1 µg RNA, 5-fold molar excess of 
protein(s) and 50-fold molar excess of 
nucleotide were used. 	  
Figure 3.28: ATP hydrolysis rate 
by eIF4A supplied with different 
amount of ssRNA15161. The 
ATPase activity of eIF4A was 
elevated 2- and 3-fold as the RNA 
concentration increased from 
5 µM to 36 µM and 100 µM, 
respectively. In each reaction, 
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Then, the shortest and best RNA candidates for crystallization of the active 
eIF4A-eIF4GN-M complex were screened. RNAs poly(A)5, poly(A)10, poly(A)15 and 
poly(A)20, as well as single stranded RNA with ~20 nucleotides and ~20-base pair 
double stranded RNA (Sequences of RNAs see Table 2.21). It turned out that the 
eIF4A-eIF4GN-M complex had the highest ability to those ssRNAs consisting of all 
the four bases, relatively strong ability to dsRNAs and lowest ability to poly-adenine 
RNAs (Figure 3.29 A). In the case of ssRNAs containing all the four bases, they had 
more or less the same shift in the agarose gel upon addition of the eIF4A-eIF4GN-M 
complex (Figure 3.29 B), indicating similar RNA-binding affinity. 
 
 
(B) EMSA of ~20 nucleotide ssRNAs and ~20-base pair dsRNA with 5-fold molar excess of 
eIF4A/eIF4GN-M. eIF4A/eIF4GN-M prefers ssRNA with all four bases. 50-fold molar excess of AMPPNP 
was used in the indicated cases. slRNA: RNAs containing a stem loop. 
Figure 3.29: Selection 
of RNA substrates for 
eIF4A/eIF4GN-M 
complex. (A) EMSA of 
poly(A)5-, poly(A)10-, 
poly(A)15- and 
poly(A)20-RNA, as well 
as ssRNAα-eGFP (21 
nucleotides) with 
5-fold molar excess of 
eIF4A/eIF4G468-853. A 
clear shifted band is 
only observed in the 
case of poly(A)20-RNA. 
Although higher 
amount of poly(A) 
RNAs (4.5 µg) were 
used, compared to 
ssRNAα-eGFP (1 µg), 
weaker bands were 
observed. This is due to 
low affinity of the 
GelRed dye to the 
poly(A) RNAs.	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3.2.2.3 Interaction test between eIF4A and eIF4B  
To study the mechanism by which eIF4B synergistically promotes the activities of 
eIF4A, series of interaction assays between eIF4A and eIF4B were performed in the 
absence and presence of RNA fragments, nucleotides and eIF4G variants. Different 
RNA oligos (double stranded, single stranded and RNA with a stem-loop; the 
sequences of RNAs see Table 2.21) and different nucleotides (ADP, ATP and 
AMPPNP) were tested. However, an interaction of eIF4B with eIF4A and/or eIF4G 
was not observed in all used experiments, including co-purification test, pull-down 
experiments, electrophoretic mobility shift assays (EMSA), or analytical size 
exclusion chromatography (SEC). This indicates that eIF4B either transiently or 
indirectly binds to eIF4A.  
Next, the ability of eIF4B to interact with RNA was tested. In the case of adding 
eIF4B, both dsRNA and ssRNA migrated slower than free RNA (Figure 3.30), 
suggesting eIF4B could bind both types of RNA. However, it possesses higher 
capability to ssRNA than dsRNA since distinct supershifted bands were observed 
for ssRNA (Figure 3.30, Lane 7, 8), while diffuse higher mobility shifts near the free 
RNA were noted for dsRNA (Figure 3.30, Lane 3, 4). eIF4B is also able to bind RNA 
with a stem-loop structure (Figure 3.30, Lane 11, 12). Whether eIF4B enhances the 
activities of eIF4A through binding and providing RNA substrates for eIF4A or 
binding to the melted single stranded RNA to prevent the annealing is still elusive. 
 
 
Figure 3.30: EMSA of single 
stranded (ss) RNA, double 
stranded (ds) RNA and 
stem-loop containing (sl) RNA 
supplied with eIF4A and/or 
eIF4B. Compared to dsRNA, 
greater shift is noted for 
ssRNA. 1 µg RNA and 5-fold 
molar excess of protein(s) were 
used in each case. 	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3.2.2.4 Preparation and crystallization of the minimal active 
eIF4A-eIF4G complex   
S. cerevisiae eIF4A and eIF4GN-M form a stable hetrodimeric complex (with 1:1 
stoichiometry) in low salt (100 mM NaCl) containing buffer (Figure 3.31 A). 
Crystallization of the eIF4A-eIF4GN-M complex produced rice-shaped crystals in a 
condition containing 1.5 M Li2SO4, 0.1 M Tris/HCl, pH 8.5 (Figure 3.31 B, upper 
panel). Optimization by varying the concentration of the salt, the type of the buffer 
and the pH resulted in more crystals (Figure 3.31 B, lower panel). However, bigger 
crystals that are suit for X-ray analysis could never be produced. 
 
Figure 3.31: Purification and crystallization of the eIF4A/eIF4GN-M complex without and with RNA. (A) 
Gel filtration purification and (B) crystals of the eIF4A/eIF4GN-M complex in the absence of RNA. The 
crystals appeared from high salt containing buffer (1.5 M Li2SO4). Optimization only produced plenty of 
tiny crystals. (C) Gel filtration purification and (D) crystals of the eIF4A/eIF4GN-M complex supplied 
with 5-fold molar excess of AMPPNP and 2-fold molar excess of ssRNAα-eGFP. ssRNA was added prior 
to loading onto the gel filtration. 
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    Since eIF4A-eIF4GN-M is able to bind RNAs, crystallization trials of the 
eIF4A-eIF4GN-M-ssRNA complex in the presence of 5-fold molar excess of AMPPNP 
were also performed. Upon addition of 2-fold molar excess of ssRNAα-eGFP, the 
eIF4A-eIF4GN-M complex eluted earlier from the Superdex 200 column, shifted from 
~180 ml to 140-150 ml (Figure 3.31C). Crystallization trials of the 
eIF4A-eIF4GN-M-ssRNA-AMPPNP complex only yielded long needle crystals from 
buffer containing 0.2 M NaCl, 20% (w/v) PEG monomethyl ether 2000, 0.1 M MES 
pH 6.0 (Figure 3.31D). These crystals could not be used for X-ray analysis and 
improved further.  
3.2.3 Monitoring the conformational change of eIF4A by 
crosslinking 
To explore the structural alterations within eIF4A that are induced by nucleotides, 
RNA and/or auxiliary proteins, the UV-reactive unnatural amino acid 
p-benzoyl-L-phenylalanine (Bpa) was introduced into the ATP-dependent helicase 
eIF4A. Eight positions along the cleft of eIF4A two RecA-like domains and three 
positions in the eIF4G-binding interface of eIF4A-NTD were selected for individual 
replacement by Bpa (Figure 3.32). All selected residues are not involved in the 
formation of secondary structures and should not impair the folding and activities of 
eIF4A. Ten out of eleven Bpa substituted mutants could be expressed and purified 
(N340B: no expression).  
For each Bpa mutant, its conformations in apo, ADP-, AMPPNP-, RNA-, RNA 
and AMPPNP-bound states were studied in the absence or presence of eIF4GM or 
eIF4GN-M. In general, two types of crosslink bands (one at high molecular weight, 
migrating above 100 kDa; another just below nonexposed eIF4A) were observed 
upon UV irradiation. Since the crosslink bands at high molecular weight appeared 
only in the presence of eIF4G variants but not in these eIF4A alone experiments, 
and considering their size, these bands are assumed to represent intermolecular 
crosslinks between eIF4A and eIF4G. Whereas the faster migrating crosslink bands 
produced in the absence and presence of eIF4G are most likely due to 
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intramolecular crosslinking within eIF4A. These intramolecularly crosslinked 
species possess UV-produced covalent bonds, which cannot be broken by SDS, and 
thus are more compact than their native counterpart. Therefore, although they 
possess the same amino acids (except the Bpa point mutation), crosslinked samples 
migrate faster in the SDS gels than native protein does.  
Generally, those intramolecular crosslink bands which would be an indication 
of a closed conformation were not observed as was expected. However, the data 
showed that the nucleotide ADP, RNA and eIF4G do trigger conformation changes 
within eIF4A as revealed by the crosslinks (see below).  
 
Figure 3.32: Positions selected for replacement by Bpa showing in half open (PDB code: 2VSO) and 
closed conformations. The closed model was made based on the structure of eIF4A III. During modeling, 
eIF4A-CTD, which is the primary eIF4G-interacting domain, is fixed, while the NTD of eIF4A is moved 
and superimposed onto eIF4A III’s NTD. 
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3.2.3.1 Binding of eIF4G induces conformational changes in eIF4A 
Three Bpa point mutants (Q67B, P205B and Q296B) suggest a substantial 
conformational change in eIF4A upon binding of eIF4G (either eIF4GM or eIF4GN-M). 
Compared to eIF4A alone, addition of eIF4G to mutant P205B resulted in a  
 
 
Figure 3.33: Crosslinking assays of P205B (A) and Q296B (B) in the absence or presence of eIF4G 
variants, nucleotides and/or RNA as labeled. Samples were exposed to the UV-light for 30 sec. The 
crosslink bands are indicated with brackets. 0': no UV exposure; Inter-Xlinks (cyan): intermolecular 
crosslinks between eIF4G and eIF4A; Intra-Xlinks (red): intramolecular crosslinks within eIF4A. 
Unlabeled protein bands represent impurities.   
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decrease of intramolecular crosslink (Figure 3.33A, Intra-Xlinks). Contrarily, in the 
presence of eIF4G, more accumulation of crosslinked sample was observed in the 
cases of Q67B and Q296B (except the ADP-bound form) (Figure 3.33 B and 3.34 A, 
Intra-Xlinks). Since the effect of eIF4G was noted not only for eIF4GN-M but also for 
eIF4GM, this conformational change in eIF4A seems to be induced by its association 
with the minimal eIF4A-binding of eIF4G (region 572-853). 
3.2.3.2 Conformational changes of eIF4A upon ADP binding 
All the three mutants (Q67B, P205B and Q296B) displayed an intriguing feature. 
Compared to the apo and AMPPNP-bound form, addition of ADP caused a reduction 
of intramolecular crosslinks (Figure 3.33 and 3.34 A). Notably, in the cases of Q67B 
and P205B, this effect of ADP is independent of eIF4G. In other words, regardless of 
presence or absence of eIF4G, a decrease of crosslink bands was observed in the 
ADP-bound state (Figure 3.33A and 3.34A). By contrast, no reduction of crosslink 
was observed in ADP-bound form of Q296B if eIF4G was absent (Figure 3.33B). 
Lower level of intramolecular crosslinks upon addition of ADP was also observed for 
E342B, which showed two different crosslink bands (Figure 3.34B, Intra-Xlinks). 
Although the lower crosslink band kept the same in all reactions, the upper one got 
week or disappeared when ADP was supplemented. The effect of ADP was also 
reflected by the intermolecular crosslinks. Upon binding of ADP, P205B generated 
less intermolecularly crosslinked species (Figure 3.33A), while Q296B produced 
more (Figure 3.33B). Additionally, in the case of D25B, stronger crosslinking 
occurred in the ADP-bound state (Figure 3.35B).  
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Figure 3.34: Crosslinking assays of Q67B (A) and E342B (B) in the absence or presence of eIF4G 
variants, nucleotides and/or RNA as labeled. Samples were exposed to UV-light for 30 sec. The crosslink 
bands are indicated with brackets. Inter-Xlinks: intermolecular crosslinks between eIF4G and eIF4A; 
Intra-Xlinks: intramolecular crosslinks within eIF4A. Unlabeled protein bands represent impurities.   
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3.2.3.3 Conformational changes in eIF4G-RBR2 upon RNA binding 
Upon UV exposure, intermolecular crosslink bands were observed for eIF4A 
mutants K23B, D25B and E43B, which are located in the eIF4G-binding interface of 
eIF4A-NTD, in the presence of eIF4GM or eIF4GN-M (Figure 3.35A, B, C). As 
mentioned above, eIF4GM (residues 572-853) contains only the eIF4A-binding 
domain, while eIF4GN-M (residues 468-853) possesses the eIF4A-binding domain 
and the adjacent N-terminal RNA-binding region (RBR). This RBR of eIF4G is the 
second RNA-binding region of full-length eIF4G, and thus named RBR2. RBR2 of 
eIF4G is indispensable for stimulating eIF4A ATPase activity (Figure 3.26).  
    In the case of eIF4A/eIF4GM, one crosslink band migrating at ~75 kDa 
appeared in each reaction (Figure 3.35 A,B,C, Lane 10-14, labeled with Xlinks 1'), 
while in general two crosslink bands at ~100 kDa (Figure 3.35A,B,C, Lane 5-9, 
labeled as Xlinks 1 and 2, respectively) were observed when eIF4GN-M was supplied. 
The upper one of the two adjacent bands (Xlinks 1) kept the same pattern as 
Xlinks 1' in eIF4GM, while the lower one (Xlinks 2) exhibited distinct behaviors in 
the presence or absence of RNA oligos. When RNA was not supplied, this 
intermolecular crosslink band (Xlinks 2) clearly emerged, indicating that a 
considerable amount of eIF4A got crosslinked with eIF4GN-M. By contrast, upon 
addition of RNA, this lower crosslinking band (Xlinks 2) is significant weaker or 
even disappears. All together, the upper crosslink bands are assumed to result from 
the crosslinking between eIF4A and the minimal eIF4A-binding domain of eIF4G 
(residues 572-853), while the lower bands are a product of specific crosslinking 
between eIF4A and the eIF4G-RBR2 (residues 468-571). RNA-effected 
intermolecular crosslinks between eIF4A and eIF4G-RBR2 were also observed for 
eIF4A mutants Q67B and E342B, which showed a decrease and increase of 
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Figure 3.35: Crosslinking assays of K23B (A), D25B (B) and E43B (C) in the absence or presence of 
eIF4G variants, nucleotides and/or RNA as labeled. Samples were exposed to the UV-light for 30 sec. 
The crosslinked bands are indicated with brackets. Xlinks 1 and 2: intermolecular crosslinking between 
eIF4G468-853 and eIF4A; Xlinks 1': intermolecular crosslinking between eIF4G572-853 and eIF4A. Xlinks 1 
and Xlinks 1' should be crosslinks occurred the same position in eIF4G. Unlabeled protein bands 
represent impurities. No intramolecular crosslinks were observed for the eIF4A K23B, D25B 
and E43B mutants. 
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4 
Discussion 
In this thesis, the functional core complex (containing eIF3a, b, c, g and i) of 
C. thermophilum eIF3 was reconstituted in vitro, and the subunit b serves as the 
major scaffold protein. In addition, the data showed that eIF3b, eIF3i and eIF3g of 
C. thermophilum are able to pairwise interact with each other. The eIF3i- and 
eIF3g-binding sites in eIF3b are both located in the C-terminal domain of eIF3b. All 
these results are consistent with studies in yeast [48,59] and present direct proofs 
that the interacting network of eIF3 is universally conserved.  
The crystal structure of the central WD40 domain of the major scaffold protein 
eIF3b from C. thermophilum was determined de novo by means of MAD. 
cteIF3b-WD40 adopts a nine-bladed β-propeller architecture. The central channel of 
the propeller possesses wide top and narrow bottom, resembling an unusual circular 
truncated cone. Structure based multiple sequence alignment and secondary 
structure prediction strongly suggested that all eIF3b orthologs employ this 
nine-bladed β-propeller fold.  
By revisiting the cryo-electron microscopy map of the 43S preinitiation complex, 
eIF3b could be localized on the 40S ribosomal subunit, underneath the shoulder of 
the 40S subunit. This placement is consistent with previous biochemical data [164], 
and is supported by our in vitro co-sedimentation and GST pull-down experiments, 
which show direct binding of eIF3b to the 40S subunit and to the isolated ribosomal 
protein rpS9e. 
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Furthermore, the expression of full-length S. cerevisiae eIF4G has been 
established using the MultiBac insect cell expression system. Pure full-length 
eIF4G and the eIF4F complex could be prepared. By testing the ATPase activity of 
eIF4A in the absence or presence of eIF4G variants and/or eIF4B, the minimal 
mRNA activation complex was determined. Although it was unable to get crystals of 
the eIF4F complex, the conformational changes within eIF4A and eIF4G were 
monitored using site-specific crosslinking experiment. 
4.1 Reconstitution of C. thermophilum eIF3 core complex  
Chaetomium thermophilum is a thermophilic fungus living at temperatures up to 
60 °C. Compared to proteins from mesophilic organisms, it has been noted that 
thermophilic proteins seem to be more stable and hence show improved properties 
for structural and biochemical investigations. Following the reconstitution studies 
of the C. thermophilum inner nuclear pore complex [165], several crystal structures 
of C. thermophilum proteins, of which their homologues from other species have 
never been crystallized, have been published [41,166,167]. These successful studies 
led us to identify and characterize subunits of eIF3 in this thermophilic eukaryote. 
Notably, 13 genes encoding eIF3 subunits were found in C. thermophilum genome, 
suggesting that cteIF3 resembles mammalian eIF3.  
    The subunits b, c, g and i of cteIF3 could be individually expressed in E. coli 
cells and purified through several purification steps (see Section 3.1.1.1). To purify 
cteIF3a, it is required to at least add cteIF3c to pass through the gel filtration 
column since eIF3a itself aggregates and sticks on the column. This reflects that 
eIF3 subunits have positive effects on each other and thus function cooperatively. In 
addition, pure cteIF3 core complex (containing eIF3a, b, c, g and i) was successfully 
assembled in vitro (Figure 3.6), which provides a basis for further structural 
analysis using either X-ray crystallography or cryo-EM. Unlike its yeast 
counterpart [59], a stable eIF3b-c-i-g subcomplex could not be reconstituted in vitro 
from C. thermophilum proteins (Figure 3.6 D). This indicates that the interaction 
between eIF3c and the eIF3b-i-g subcomplex is either not universal and therefore 
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might not be essential for the assembly of the eIF3 complex, or depends on the 
presence of additional subunits of eIF3 in C. thermophilum. 
    As reported, human eIF3a expressed in bacterial cells missed its C-terminal 
half, while the N-terminal third of eIF3c is truncated [168]. Rabbit eIF3 complex 
encounters similar truncation problem as isolated eIF3 from rabbit reticulocyte 
lysate contains at least half truncated eIF3a as well [61]. Since C. thermophilum 
contains all 13 eIF3 subunits and proteins from it are more stable (revealed by our 
limited proteolysis experiments), it is good to expand the targets of interest to 
C. thermophilum eIF3 proteins, and further obtain the complete eIF3 complex for 
dissecting the structure and function. 
4.2 The nine-bladed β-propeller fold of eIF3b-WD40  
WD40 propellers differ widely in the composition and length of sequence, resulting 
in various numbers of blades. So far, four- to ten-bladed WD40 β-propellers have 
been structurally identified, among which the seven-bladed propellers are the most 
abundant in the Protein Data Bank (PDB), followed by six and eight repeats 
[138,169]. The WD40 domain of eIF3b adopts a nine-bladed fold, although it has 
been predicted to fold into two tandem β-propellers [46]. The overall diameter of the 
propeller is up to 53 Å, which is 7 Å and 11 Å larger than eight- and seven-bladed 
propellers, respectively. Most of the four- to eight-bladed WD40 β-propellers possess 
cylindrical central channels. Different from this feature, the central channel of 
eIF3b-WD40 propeller resembles a circular truncated cone shape. However, the 
reason for this arrangement is currently unclear.  
By the time the structure of eIF3b-WD40 was solved, it represented the first 
nine-bladed β-propeller fold. It was tried to find whether other proteins beyond 
eIF3b orthologs also employ a nine-bladed fold using bioinformatics methods. By 
searching the NCBI conserved domain database (CDD) [170] eIF2A (implicated in 
promotion of initiator tRNA binding to the 40S in internal ribosome entry 
site-mediated (IRES) translation initiation) was identified as a candidate. 
Secondary structure prediction of eIF2A assigns 36 β-strands, exactly matching the 
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strand number of a nine-bladed β-propeller. However, other WD40 proteins that 
adopt a nine-bladed fold were not verified. This might be due to the high degree of 
sequence degeneracy among WD40 domains and the limitation of current prediction 
tools, which make the prediction of the correct blade numbers and domain 
boundaries extremely difficult. Surprisingly, the crystal structure of S. pombe 
eIF2A was reported online recently, revealing a nine-bladed β-propeller architecture 
as predicted [171]. Structures of eIF2A-WD40 and eIF3b-WD40 superimpose well 
with an r.m.s.d. of 1.79 Å for 300 common Cα atoms (Figure 4.1), although the 





Figure 4.1: Superposition of eIF3b-WD40 (blue) and eIF2A-WD40 (green) showing in top view (A) and 
side view (B). The two structures superimpose well with r.m.s.d. of 1.79 Å for 300 common Ca atoms. 
4.3 Localization of eIF3 on the 40S ribosomal subunit  
Significant efforts have been made to map the interaction sites of eIF3 on the 40S 
subunit. It has been determined that the three largest subunits (a/Tif32, b/Prt1 and 
c/Nip1) play the pivotal role in association with the 40S subunit [164]. eIF3a binds 
to the ribosomal protein rpS0 and rpS1e via its NTD, while eIF3a-CTD interacts 
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with rpS2e, rpS3e as well as the helices 16-18 of the ribosomal RNA 18S 
[1,15,55,61,62]. eIF3c also directly binds to ribosome through the interaction with 
RACK1 [56]. By contrast, the interaction between eIF3b, the major scaffold subunit 
of eIF3, and the 40S subunit is mediated by another eIF3 subunit, eIF3j, which is 
not universally conserved [47]. This indirect interaction to some extent would affect 
the promotion efficiency of the multifactor complex by eIF3 to the ribosome.  
Based on the cryo-EM map of the DHX29 bound 43S PIC (EMDB code: 5658) 
[61], eIF3b was localized underneath the shoulder of 40S and adjacent to rpS9e 
(Figure 3.16 and 4.2). This position of eIF3b seems to be rather far away from the 
eIF3a- and c-containing octameric complex of eIF3 (including subunits a, c, e, k, l, m, 
f and h) (Figure 3.16 and 4.2). However, in the 43S PIC, eIF3a is actually lacking 
the C-terminal ~600 amino acids, which possess the binding site for eIF3b [15]. 
Hence, the missing subunits (eIF3d, g, i and j) and flexible regions of eIF3 would 
sufficiently link eIF3b and the octameric complex. 
 
 
Figure 4.2: eIF3 octamer (light blue) and eIF3b-WD40 (blue) bound 40S ribosomal subunit, showing the 
solvent-exposed side. The model is made based on the cryo-EM map of the DHX29 bound 43S PIC 
(EMDB code: 5658), and the PDB code of the 40S subunit structure is 4KZZ. The ribosomal proteins 
and RNA fragments that are involved in the interaction with eIF3 are labeled. sh: shoulder of the 40S 
subunit; bk: beak of the 40S sununit.  
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Based on the placement, a direct interaction between eIF3b and the 40S 
subunit has been identified for the first time (in collaboration with S. Schell and 
A. Chari). Full-length eIF3b and eIF3b167-670 co-sedimented with the purified 40S 
subunit (Figure 3.18). In addition, full-length eIF3b and eIF3b167-C were pulled 
down by the GST tagged rpS9e, while eIF3b167-670 did not (Figure 3.19). These 
results indicate at least two binding sites within the 40S subunit for eIF3b. (i) The 
ribosomal protein rpS9e interacts with the last 42 C-terminal amino acids (residues 
705 to 746), since this fragment is indispensable for association with the 40S 
subunit (Figure 3.19). eIF3b705-746 contains highly conserved residues across yeast to 
human (Figure 3.14). (ii) The WD40 domain plus the following 30 residues 
(eIF3b167-670) bind to other region(s) of the 40S subunit. eIF3b167-670 was used 
because the WD40 domain itself precipitated in the 40S subunit buffer. Based on 
the structural modeling, it is proposed that the helix 16 and ES6S-hA of the 
ribosomal RNA (18S) could be involved in this interaction. The potential residues of 
eIF3b that mediate the association with the 40S subunit are these conserved basic 
and aromatic residues, for example, K434, K462 (with h16); R592, R635 and the 
cluster 646-659 (K646, R649, K650, R653, Y655, R657, F659) (with ES6S-hA). 
However, to validate the specific intermolecular bridges between eIF3b and the 40S, 
further work is needed.  
The direct interaction between eIF3b and the 40S provides new insight into the 
eIF3·40S interaction network and suggests an essential role of the central scaffold 
subunit b of eIF3 in the formation of the 43S PIC. Our studies provide a structural 
basis for dissecting the mechanisms of the assembly of 43S and 48S PIC.  
4.4 RNA substrate of eIF4A 
eIF4A plays an essential role in the cap-dependent translation initiation by melting 
the secondary structures in the 5’-untranslated region of mRNA to facilitate binding 
of the 40S subunit and to enable subsequent scanning for the AUG start codon. 
However, eIF4A has its own ‘specific’ RNA substrate for unwinding. This specificity 
does not dependent on the length nor the nucleotide sequence, but the overall 
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stability (ΔG value), of the duplex substrate. It has been demonstrated that the 
initial rate and the amplitude of duplex unwinding by eIF4A is correlated with the 
stability of the secondary structure element [23]. eIF4A is only able to efficiently 
separate secondary structure of RNA having relative low stability (with less 
negative ΔG value, ~−24 kcal/mol) [88]. To translate those mRNAs with highly 
structured 5’ UTR, other helicases are needed. The DEAD/DExH-box mammalian 
proteins DHX29, DDX3 and RNA helicase A (RHA), as well as yeast Ded1p have 
been implicated in translation initiation [24,27].  
    This could explain why it was observed an unwinding by eIF4A/eIF4B/eIF4GN-M 
(which exhibited high ATP hydrolysis rate) when an RNA duplex with ΔG= −65.0 
kcal/mol was used. This RNA substrate was chosen as an initial test because it was 
readily available. Further experiments will require fluorescence-dye labeled RNA 
with low stability (ΔG= −19.8 kcal/mol) according to the requirement of eIF4A. 
Systematic helicase activity assay will be performed soon. 
4.5 Regulation of eIF4A activity by eIF4G and eIF4B  
DEAD-box (and related DExH-box) helicases melt secondary structures of RNAs in 
an ATP-dependent manner and function in all aspects of RNA metabolism, 
e.g. transcription, mRNA splicing, translation, ribosome biogenesis, RNA 
modification and degradation, etc [80,172]. The majority of helicases from this 
family contains N- and/or C-terminal extensions flanking the helicase core. These 
extensions have been demonstrated to modulate interactions with ATP, RNA 
substrate or protein partners [81,82,173]. However, the archetypical member of the 
DEAD-box protein family, eIF4A, consists of the helicase core only. To efficiently 
melt the duplex in the RNA, eIF4A requires the assistance of auxiliary proteins 
[88,174]. 
It has been known that eIF4G and eIF4B (as well as eIF4H in mammalian cells) 
can promote the ATPase and helicase activities of eIF4A for more than decade 
[76,79]. Since the time of discovery, extensive studies were performed to understand 
the mechanism of this stimulation by eIF4G and eIF4B. So far, it is believed that 
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eIF4G enhances the enzymatic activities of eIF4A by inducing a more compact 
conformation (compared to the apo form) of eIF4A, through the direct interaction 
with eIF4A [108]. In this so-called ‘half open’ conformation, all the functional motifs 
of eIF4A are pre-arranged for the activation. Thus, the minimal eIF4A-binding of 
eIF4G (yeast eIF4GM (residues 572-853)) is thought to be the actual effector region. 
Consistently, it has been reported that yeast eIF4GM is able to increase the ATP 
hydrolysis rate by 3- to 5-fold [86,108]. However, in the ATPase activity assay 
studied in this thesis, there is no enhancement appearing at all (Figure 3.26). In 
this thesis, 1 µM of proteins and 5-fold molar excess of RNA (i.e. 5 µM) were used for 
the ATPase activity assays, which is reasonable. By contrast, in those assays that 
noted 3- to 5-fold stimulation, up to 1 mM (1000 molar excess to protein) RNA was 
used to reach the saturation [86,108]. Basically, this high ratio of RNA to protein is 
unlikely to represent physiological conditions. It has been reported that high 
substrate concentration and crowded environment do enhance the ATPase activity 
of eIF4A [175]. 
The ATPase activity experiment and electrophoresis mobility shift assay in this 
thesis revealed that the extent of the stimulation by eIF4G to the ATPase activity of 
eIF4A correlates with the RNA-binding ability of eIF4G (Figure 3.26 and 3.27). The 
eIF4G variant that displays the highest enzymatic stimulation (i.e. eIF4GN-M 
(residues 468-853)) also exhibits the strongest RNA-binding ability. By contrast, 
eIF4GM shows lowest RNA-binding affinity and no enhancement to eIF4A activity. 
Thus, eIF4G is proposed to promote the activities of eIF4A through the interaction 
with both eIF4A and RNA, thus recruiting the RNA substrate for eIF4A. Hence, as 
RNA is necessary for efficient ATPase and helicase activities of eIF4A, eIF4GM 
shows no stimulatory effect.  
This proposal was further corroborated by our site-specific UV-induced 
crosslinking experiments. eIF4A mutants K23B, D25B and E43B (located at the 
eIF4G-binding interface of eIF4A-NTD (Figure 3.32)) substantially crosslinked with 
eIF4GN-M in the absence of RNA, whereas the crosslinks were significantly reduced 
in the presence of RNA (Figure 3.35). The extent of the crosslink reflects the 
accessibility of crosslinked region(s) to the Bpa positions. A mutant located at the 
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upper side of the cleft of the two RecA-like domains of eIF4A (Q67B) showed similar 
results (Figure 3.34 A). By contrast, upon addition of RNA, more crosslink sample 
was observed for a mutant carrying Bpa adjacent to the RNA-binding region of 
eIF4A (E342B) (Figure 3.34 B). As described before (Section 3.2.3), these 
intermolecular crosslinks most likely occurred between eIF4A and the second 
RNA-binding region (RBR2, residues 468-571) of eIF4G. Together, the crosslinking 
studies indicate a substantial conformational change within the RBR2 of eIF4G. In 
the absence of RNA, the eIF4G-RBR2 is flexible and reaches the eIF4G-binding 
interface of eIF4A-NTD. Whereas in the presence of RNA, the eIF4G-RBR2 binds 
the RNA and this RNA-binding places eIF4G-RBR2 to the vicinity of eIF4A 
RNA-binding region (Figure 4.3). The data implicate a role of the RBR2 of eIF4G in 
directly providing RNA substrate for the eIF4A and thus enhancing its activities. 
 
 
Figure 4.3: Conformational change of eIF4G-RBR2 upon RNA binding. The structures of eIF4G 
(orange) and eIF4A (blue and cyan) are shown in cartoon, while the RNA-binding region 2 of eIF4G 
(RBR2) is indicated with dashed lines. In the absence of RNA, the RBR2 of eIF4G is flexible and 
reaches the eIF4G-binding interface of eIF4A-NTD. In the presence of RNA, eIF4G-RBR2 binds the 
RNA and accesses the vicinity of eIF4A RNA-binding region. 
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eIF4B also showed a stimulation of the ATPase activity of eIF4A when eIF4G 
was present (Figure 3.26). However, a direct interaction of eIF4B with eIF4A, 
eIF4G or the eIF4A/4G complex was not observed (Section 3.2.2.3). It has been 
reported that eIF4B works in conjunction with eIF4G to induce a closed 
conformation of eIF4A [174]. However, how eIF4B contributes to this action is 
current unclear. Notably, eIF4B stimulates the ATPase activity of eIF4A only when 
eIF4G variants that possess RNA-binding ability are present, which indicates a 
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Abbreviations 
Abbreviation Expanded 





ADP adenosine diphosphate 
BisTris Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane  
Bpa p-benzoyl-L-phenylalanine 
CTD C-terminal domain 
cryo-EM Cryo-electron microscopy 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
dsRNA double-stranded RNA 
DTT 1,4-Dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
e.g. exempli gratia 
eIF eukaryotic translation initiation factor 
EMSA electrophoretic mobility shift assay 
GST Glutathione S-transferases 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
i.e. id est 
IRES Internal ribosome entry site 
IPTG isopropyl-β-D-1-thiogalactopyranoside 
kDa kilodalton (unit of molecular weight) 
kcat catalytic constant 
KM Michaelis constant 
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Abbreviation Expanded 
m7G 7-methylguanosine 
MAD multi-wavelength anomalous dispersion 
MR molecular replacement 
mRNA messenger RNA 
NMR nuclear magnetic resonance 
NTD N-terminal domain 
PCR polymerase chain reaction 
PIC preinitiation complex 
poly(A) poly-adenine 
r.m.s.d. root mean square deviation 
RNA ribonucleic acid 
SEC size exclusion chromatography 
SDS sodium dodecylsulfate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
TEMED N,N,N',N'-tetraethylenediamide 
TRIS tris-(hydroxymethyl)-aminomethane 
tRNA transfer RNA 






	   132 
	    
Acknowledgements 
	   133 
Acknowledgements 
I am truly grateful to my supervisor Prof. Dr. Ralf Ficner. I sincerely appreciate all 
his support, encouragement and great guidance during my 3.5-year Ph.D study. I 
would like to acknowledge Prof. Dr. Wolfgang Wintermeyer and Prof. Dr. Holger 
Stark for the fruitful discussions and helpful suggestions during the thesis 
committee meetings. I am truly thankful to Prof. Dr. Reinhard Lührmann, 
Prof. Dr. Jörg Stülke and Prof. Dr. Kai Tittmann for being members of my extended 
thesis committee. 
In addition, I appreciate that Prof. Dr. Holger Stark offered me an opportunity 
to work in his lab for an important experiment. I would also like to thank all people 
from his group for their kindness and friendship. I am very thankful to Dr. 
Stephanie Schell and Dr. Ashwin Chari for the kind help and brilliant advises 
during the period that I was working with them.  
I express my sincere thanks to all former and current members of the 
Department of Molecular Structural Biology for their friendship and great working 
atmosphere. I am special grateful to Bernhard Kuhle for extensive discussions, 
brilliant suggestions and great company. I appreciate Dr. Piotr Neumanm for his 
help on diffraction data collection and structure determination. 
I want to thank Bernhard Kuhle, Dr. Yasar Luqman Ahmed, Dr. Thomas 
Monecke and Dr. Po-chia Chen for critically reading and correcting parts or whole of 
this thesis. 
    I am forever indebted to my parents and Fengbiao for their unconditional 
support and endless love. I would also like to express my deepest gratitude to all my 
friends for their great company, encouragement and love. 
  
 
	   134 
  
CV of Yi Liu 
	   135 
CURRICULUM VITAE OF YI LIU  
PERSONAL INFORMATION                
w Given Name, Surname: Yi, Liu 
w Gender: Female 
w Nationality: Chinese 
w Current Position: Ph.D student in Department of Molecular Structural Biology, 
Goettingen University, Germany 
w E-mail:	  yi.liuzhou@gmail.com	   	  
UNIVERSITY EDUCATION                                                   	  
2010.12 – Now Ph.D student in Department of Molecular Structural Biology, 
Goettingen University 
Supervior: Prof. Dr. Ralf Ficner 
Ph.D Thesis Project: Structural and functional studies on 
proteins involved in eukaryotic translation 
initiation 
2007.09 – 2010.07 Master student in Biochemistry and Molecular Biology, 
Institute of Biomedical Science (IBS), Fudan University, 
Shanghai, China 
Supervior: Prof. Dr. Yanhui Xu 
Master Thesis Project : Structural and functional studies of a  
complex in mTOMC pathway 
2003.09 – 2007.07 BSc (first class) in zoology, Department of Food Science, 
Jiangnan University, Wu Xi, China 
 
